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ANALYSIS OF THE BIOCHEMICAL AND CELLULAR ACTIVITIES OF SUBSTRATE BINDING BY 
THE MOLECULAR CHAPERONE HSP110/SSE1 
 
Veronica Margarita Garcia, B.S. 
Advisory Professor: Kevin A. Morano, Ph.D. 
 
Molecular chaperones ensure protein quality during protein synthesis, delivery, damage 
repair, and degradation. The ubiquitous and highly conserved molecular chaperone 70-kDa heat-
shock proteins (Hsp70s) are essential in maintaining protein homeostasis by cycling through high and 
low affinity binding of unfolded protein clients to facilitate folding. The Hsp110 class of chaperones 
are divergent relatives of Hsp70 that are extremely effective in preventing protein aggregation but 
lack the hallmark folding activity seen in Hsp70s. Hsp110s serve as Hsp70 nucleotide exchange factors 
(NEF) that facilitate the Hsp70 folding cycle by inducing release of protein substrate from Hsp70, thus 
recycling the chaperone for a sequential round of folding and allowing successfully folded substrates 
to exit the folding cycle. In the model organism Saccharomyces cerevisiae, Hsp110 is represented by 
the proteins Sse1 and Sse2, which possess an Hsp70-like substrate binding domain (SBD), making 
them unique among other functionally similar, but structurally distinct, NEFs. Studies of Hsp110 and 
Sse1 have demonstrated that this chaperone/NEF family can bind polypeptides and prevent proteins 
from aggregating in vitro and that this ability is conferred by the SBD. However, attempts to study 
Hsp110 protein binding in vivo have not been successful. To date, the impact of peptide binding by 
Hsp110 is unknown. This study elucidates and defines substrate binding by the yeast Hsp110 and 
addresses the contributions of this activity toward protein and cellular homeostasis as well as begins 
inquiries into substrate binding by the Drosophila melanogaster Hsp110, Hsc70cb. As a major partner 
of Hsp70, determining cellular Hsp110 activities is a prerequisite to a full understanding of chaperone-
mediated protein homeostasis. By studying chaperone functions and activities in yeast and animal 
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models, we can understand human cellular protein quality control systems which can then be 
pharmacologically targeted to combat protein conformational disorders, including Alzheimer’s, 
Huntington’s, and Parkinson’s diseases. 
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Chapter 1: Introduction 
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Stress and protein quality control 
 
Most cellular functions are carried out by proteins which must fold into a proper three-
dimensional configuration, or native state. Nascent polypeptides possess all the biophysical 
information required to achieve the native state, but the process of protein folding is complex and 
often vulnerable to translation errors and environmental factors (1-4). As newly synthesized proteins 
exit the ribosome, these unfolded polypeptides run the risk of misfolding or aggregating. Large 
complex polypeptides cannot acquire their proper secondary or tertiary structure until the entire 
necessary domain or domains required for proper folding have exited the ribosome (5, 6). 
Exponentially growing yeast contain approximately 105 active ribosomes per cell (7, 8). In typical 
mammalian cells approximately 106 to 107 ribosomes are translating RNA into protein (9). This much 
ribosomal activity within one cell necessitates the aid of a network of molecular chaperones to 
maintain a functional proteome. Molecular chaperones help other proteins achieve their native 
conformations by stabilizing folding intermediates without becoming part of the final structure of 
those proteins (5). 
Under optimal conditions, molecular chaperones help in de novo protein folding, repairing 
misfolded substrates, maturation and translocation of proteins, and promoting the degradation of 
irreparable proteins (5, 10). Chaperones act as a cellular quality control system and protect newly 
synthesized polypeptides by binding the exposed hydrophobic regions of unfolded proteins. They 
preventing aggregation and allow proteins to fold in a protective environment thus preventing 
premature degradation (11). In addition to promoting nascent polypeptide folding, chaperones repair 
proteins that are damaged post-translation. For example, when cells are exposed to heat stress, 
damaged proteins segregate into aggregates until chaperones rescue and refold them (12-14). 
Producing proteins is energy and resource intensive therefore the protein quality control machinery 
first attempts to repair proteins where energy has already been spent (15). While chaperones 
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typically function as protein folding machines, they play an important role in determining when a 
protein is fatally damaged and repair is not a possibility.  Chaperones have to recognize misfolded 
proteins and facilitate their refolding to avoid protein aggregates. When this fails or the misfolding is 
irreversible, chaperones have to recognize this terminal state and target the protein for degradation 
(16). Irreparably misfolded proteins are delivered for proteolysis and eradicated by the ubiquitin 
proteasome system which tags substrates with ubiquitin and delivers them to the 26S proteasome 
(17). This process is part of protein quality control and depends on molecular chaperones cooperating 
with specific ubiquitin protein ligases (18-20). 
Proteostasis can be defined as the balance of biosynthetic and turnover activities of the 
proteome (21). Proteomic stress such as fluxes in pH, temperature, or reactive chemical compounds 
can wreak havoc on proteostasis and may cause proteins to misfold and aggregate. These stresses 
induce the expression of chaperones through activation of the unfolded protein response (UPR) or the 
heat shock response (HSR) in the ER or the cytosol respectively (22-24). The heat shock response is a 
transcriptional activation that induces protective genes encoding molecular chaperones, or the Heat 
shock Protein (HSPs) (25) .  Chaperones are classified according to their molecular weight, i.e. Hsp40, 
Hsp70, Hsp90, and Hsp110 and into classes by functional similarity. Stress-induced stimulation of the 
HSR is important to combat the serious risk of unfolded protein accumulation that can result in the 
formation of aggregates that can be detrimental to cell health (26). Furthermore, aggregate 
associated sequestration of chaperones can lead to a deficit of chaperone-mediated activities. For 
instance, cellular functions such as clathrin-mediated endoctytosis are dependent on a consistent 
pool of chaperones (27). The HSR and HSPs are required for cells to recover from, adapt to, and 
resume growth under stress conditions that may perturb cellular proteostasis (28). 
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The Hsp70 machine 
  
Heat shock protein 70 (Hsp70) chaperones are highly conserved and ubiquitous, and they 
possess an astounding functional diversity considering the high level of conservation among homologs 
and across species. These chaperones are central players in proteome maintenance as they are 
involved in folding of nascent polypeptides, delivering proteins to different organelles, refolding 
damaged proteins, and targeting proteins for degradation that are terminally misfolded.  
Hsp70 recognizes its substrates by the exposed hydrophobic regions of unfolded polypeptides 
and binds a stretch of approximately seven amino acids rich in aliphatic residues (29-30). Its function 
is fundamentally an activity executed by nucleotide-dependent cycles of substrate binding and 
release. Hsp70 requires the J-domain (also known as J-proteins and Hsp40) and nucleotide exchange 
factor (NEF) to drive the ATP cycle and the promiscuous client recognition. 
The canonical Hsp70 protein is divided into two major domains. The amino-terminal ATPase is 
known as the nucleotide binding domain (NBD) (44 kDa) whereas the carboxy-terminus includes a 
substrate binding domain (SBD) (27 kDa) that can be subdivided into a β-domain and an α-domain 
(Figure 1-1) (31, 32). Hsp70 possess a nucleotide-driven interdomain communication that causes 
conformational changes based on its ATP or ADP binding state (33-35). The SBD binds substrates 
through a binding cleft in the SBD β. When Hsp70 is ADP-bound, substrate binding switches to a high 
affinity state due to a domain reorientation which is driven by ATP hydrolysis in the NBD.  The 
conformational change in Hsp70 induces a “clamping down” of the SBD α on the SBD β to confer high-
affinity substrate binding (34-37). Hsp70 must cycle between high- and low-binding affinity states in 
order to allow protein clients to fold.  
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Figure 1-1 Comparative representation of Hsp70 and Hsp110 proteins. Both proteins are structurally 
divided into two major domains which are the nucleotide binding domain (NBD) at the N-terminus 
and the substrate binding domain (SBD) at the C-terminus. Hsp110 possess an extender spacer region 
between the beta sandwich (SBD β) and the alpha helical bundle (SBD α) at the C-terminus. 
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The different nucleotide-dependent binding states are regulated by cochaperones. At basal 
levels, Hsp70 has a very low rate of ATPase activity and nucleotide exchange. The basal ATP hydrolysis 
rate of the bacterial Hsp70 is 0.040 ± 0.007 min-1 and the nucleotide dissociation rates of various yeast 
and human Hsp70s ranges from 0.2-0.5 s-1  (33, 38-40). This characteristic low level of ATPase and 
nucleotide exchange activity is accelerated by the Hsp40 chaperones (also known as J-proteins) and 
nucleotide exchange factors to accelerate both activities and promote functional cycling (Figure 1-2). 
Hsp40 proteins induce the intrinsic ATPase of Hsp70 causing a conformational change that increases 
the affinity of client binding (41-43). The NEFs promote a recycling of Hsp70 by triggering the release 
and exchange of ADP for ATP (39, 44-46). They bind to the Hsp70 NBD inducing a conformational 
change in that domain that triggers the release of the ADP nucleotide (47). When the nucleotide is 
ejected from the NBD, Hsp70 returns to a low affinity binding state and the bound substrate is 
released (40, 48). A new ATP molecule is bound by the NBD and a new Hsp70 folding cycle begins. 
Hsp70 functional specificity can be ascribed to these cochaperones which are more adapted to 
specific functions.  
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Figure 1-2. Cooperative folding by Hsp70, Hsp40, and Hsp110. The nucleotide dependent Hsp70 
protein folding cycle proceeds with the help of the cochaperones Hsp40 and nucleotide exchange 
factors (NEF) to produce a folded protein. The NEF depicted here is the Hsp110. The unfolded 
polypeptide is depicted as a dotted line and as a solid line when fully folded. 
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Hsp40 chaperones are classified based on the J-domain, a 70-amino acid domain containing a 
conserved histidine-proline-aspartate (HPD) tripeptide sequence modeled in the bacterial DnaJ (42). 
All Hsp40s have the J-domain in common, but they can have many other domain variations. 
Additionally, Hsp40s are classified as type I, type II, or type III by the similarity of each chaperone to 
DnaJ outside of the J-domain (49). The HPD allows J-proteins to interact with the Hsp70 NBD, 
prompting its intrinsic ATPase activity (50, 51). Hsp40s induce the ATPase of Hsp70 to increase 
substrate binding affinity but can also bind substrate clients themselves (52). Based on in vitro 
characterization, a triprotein complex is formed where Hsp40 recognizes and binds unfolded proteins 
and presents the substrate during the interaction with the Hsp70 NBD (53, 54). J-domain proteins 
increase the effectiveness of the Hsp70 protein folding machine by binding chaperone substrates and 
delivering them to Hsp70 (52, 55-56). In yeast, either of the two major cytosolic Hsp40s, Ydj1 or Sis1, 
and their substrate binding function is required to maintain cell viability (57). These data are evidence 
that Hsp40 activities include inducing ATP hydrolysis in Hsp70 and facilitating substrate recognition 
and binding by Hsp70.  
Although Hsp70 possesses a low rate of intrinsic nucleotide exchange activity in vitro, NEFs facilitate 
nucleotide exchange and are clearly vital for Hsp70 function in vivo as absence of cytosolic NEF 
function is lethal in yeast (33, 39, 45, 58). As previously mentioned, the NEFs allow for the quick 
nucleotide cycling required of Hsp70. They make contact with the bi-lobular Hsp70 NBD and cause it 
to collapse around the ADP molecule so the nucleotide-binding pocket cannot function (46, 59, 60). 
Release of the hydrolyzed nucleotide leaves the NBD free to bind another ATP molecule and begin a 
new Hsp70 folding cycle. NEFs can be classified into four unrelated groups: homologs of the protein 
GrpE from Escherichia coli, the human Hsp70-binding protein 1 (HspBP1), the Bcl-2 associated 
athanogene (BAG) proteins, or the Hsp110 proteins. Unlike the J-domain of Hsp40s, there is no 
functional domain that is common to the NEFs. While all NEFs make contact with the Hsp70 NBD to 
perform the nucleotide exchange activity, the varied structure of each NEF class dictates a different 
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mechanism of Hsp70 interaction (61, 62). For example, HspBP1 contains four α-helical repeats that 
constitute an armadillo-like domain that makes contact with Hsp70 (63). Hsp110 proteins are 
divergent members of the Hsp70 family of proteins. They interact with Hsp70 through their own NBD 
and their C-terminus (59). Even though the NEFs vary in structure and domain composition, they all 
interact with the same region of the Hsp70 NBD (64). 
 
Hsp70•Hsp40•NEF complexes throughout the yeast cell 
 
 In the Saccharomyces cerevisiae cytosol, Hsp70 is represented by two families of proteins. The 
Ssa family is encoded by SSA1-4 (Stress-Seventy subfamily A) which share functional homology and 
are differentially transcriptionally regulated (65). The SSA1 and SSA2 isoforms are constitutively 
expressed while SSA3 and SSA4 are stress inducible under the control of the Hsf1 transcription factor 
(66). The Ssb family is encoded by SSB1-2 (Stress-Seventy subfamily B) which are functionally 
interchangeable (66). Ssa chaperones can fulfill some Ssb functions, but Ssb cannot fulfill all Ssa 
functions as deletion of all SSA isoforms is lethal (67). Ssb chaperones are regulated in a similar 
fashion to ribosomal proteins and their transcription is reduced upon heat shock of yeast cells (68, 
69). There are 13 cytosolic and nuclear Hsp40s in yeast that are involved in cytosolic general protein 
folding, peroxisomal import, ribosome biogenesis, and vesicle trafficking (65). Of these, Caj1 and 
Cwc23 are strictly localized in the nucleus (70). The yeast cytosol possesses three classes of cytosolic 
NEFs, with human orthologs: the Hsp110-type proteins Sse1/Sse2 (Stress-Seventy subfamily E), the 
HspBP1-type protein Fes1 (Factor Exchange for Ssa1p) and the BAG-1-type protein Snl1 (Suppressor of 
Nup116-C Lethal) (71-75). 
Protein folding in the cytosol and nucleus is executed by an overlapping chaperone network. 
The Hsp40s, Ydj1 (Yeast DnaJ) and Sis1 (SIt4 Suppressor), help the cytosolic Hsp70 Ssa prevent protein 
aggregation (52). Although both Ydj1 and Sis1 enhance the ability of Ssa to reactivate unfolded 
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proteins, Ydj1 is more effective at inducing this Ssa behavior than Sis1. Furthermore, Ydj1 is essential 
to help cells cope with heat stress and in its absence are non-viable (52, 76). Large aggregate 
resolubilization by Hsp70 requires the concerted effort of the ATP-dependent Hsp100 family of 
proteins (26). In yeast, these proteins are located in the cytosol and in the mitochondrion to provide 
compartment-specific protection by interacting with the local Hsp70s (77). Hsp104, a member of the 
Hsp100 family, is greatly induced upon thermal stress and functions to reactivate aggregated proteins 
by translocating polypeptides through the ring formed by its hexameric complex (26). Hsp100 
chaperones act cooperatively with the Hsp70 machine to dissaggregate and reactivate misfolded 
proteins (1). 
The high expression of Ssb during cell growth is consistent with its primary function of folding 
nascent chains on translating ribosomes along with the ribosome associated complex (RAC). RAC is a 
heterodimer complex that works exclusively at the ribosome and is composed of the Hsp40, Zuo1 
(ZUOtin), and the atypical Hsp70, Ssz1 (Stress-Seventy subfamily Z) (78). Ribosomal interactions of Ssb 
through RAC are conferred exclusively via Zuo1 which induces the ATP hydrolysis in Ssb. A charged 
region within the Zuo1 structure mediates RAC binding to Rpl31, a protein at the ribosomal tunnel 
exit (79-81). Ssb binds the unfolded polypeptide, dissociates from the ribosome, and interacts with 
NEFs in the cytosol to complete de novo folding activities (45, 82, 83). Although Ssb has the prominent 
role in folding newly synthesized proteins and ribosomal interaction, Ssa can fulfill this function in the 
absence of Ssb (84). In addition to their de novo folding activities, Ssa and Ssb coordinate with Jjj1 
(Hsp40), RAC, and NAC (Nascent Polypeptide-Associated Complex), in the assembly of new ribosomes 
(85).  
The cytosolic Hsp70 in yeast are also responsible for endoplasmic reticulum (ER) protein 
translocation and for nuclear transport across the nuclear membrane (86). Ssa1 binds precursor 
proteins prior to their import in to the ER (87) . Ssa1 is also involved during nuclear transport by 
targeting protein to the nuclear membrane and during the translocation phase (88). Ssb is exported 
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from the nucleus because it possesses a C-terminal nuclear export sequence (NES). Removal of the 
NES is sufficient for Ssb to stimulate nuclear transport similar to Ssa. In the nucleus, Ssa also regulates 
the transcription factor Hsf1, the master regulator of the HSR. Ssa1 and Ssa2 bind Hsf1 to repress its 
activity during non-stress conditions (24) (unpublished data from Sara Peffer, Morano Laboratory). 
Protein residents of the ER and the mitochondrion are physically separate from the cytosolic 
environment; therefore, they require their own chaperone network with specific Hsp70 machines. 
The ER is an undulating organelle where nascent proteins are folded and processed before being 
trafficked by Golgi vesicles. Protein processing and the maturation in the ER are facilitated by a 
dedicated Hsp70 network. The ER possesses one canonical Hsp70, Kar2 (KARyogamy), four Hsp40s, 
and two NEFs (65). Three of the four Hsp40s in the ER are membrane anchored and face the lumen 
whereas Scj1 is not anchored and diffusible. Scj1 cooperates with Kar2 to chaperone an array of ER 
luminal proteins (89). Translocation into the ER lumen occurs both co-translationally, as proteins are 
synthesized, and post-translationally, as a fully synthesized polypeptide released from the ribosome. 
During translocation, Kar2 is recruited by Sec63, an Hsp40 protein, to the translocon complex which 
stimulates the ATPase activity of the Hsp70 and facilitates the transport of a polypeptide chain across 
the ER translocon (90). Lhs1 (Lumenal Hsp Seventy) and Sil1 (Suppressor of the Ire1/Lhs1 double 
mutant), are redundant NEFs and function as cochaperones for Kar2 during protein translocation (91).  
Perturbations in the ER homeostasis that cause protein misfolding trigger the UPR, causing 
proteins to be ejected from the ER in a process known as ERAD (Endoplasmic Reticulum Associated 
Degradation). Jem1 (DnaJ-like protein of the ER Membrane) and Scj1 (S. Cerevisiae DnaJ) are Hsp40s 
that function redundantly during Kar2-mediated ERAD substrate selection (92). Lhs1 plays a role in 
refolding protein aggregates after stress and its substrate binding activity is vital to turnover of ER 
proteins through ERAD (93, 94).  
Given the different environments in the mitochondrion created by the dual membrane 
system and its two compartments, protein folding and quality control requires a dedicated set of 
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chaperones. The Hsp70 machines in the mitochondrion are comprised of three Hsp70-type 
chaperones, Ssc1/3 (Stress-Seventy subfamily C) and Ssq1 (Stress-Seventy subfamily Q), five Hsp40-
type, and one NEF; all of which localize to the mitochondrial matrix (65). The GrpE-like Mge1 
(Mitochondrial GrpE) is the sole NEF, so the Hsp70s compete for interaction to fulfill their respective 
functions (95, 96).  
The primary roles for Ssc1 are in protein translocation into the mitochondrion through interactions 
with the translocase complexes, Tom and Tim, followed by protein folding in the matrix (97, 98). Ssc3 
is 82% identical to Ssc1 and also associates with unfolded proteins during and after translocation, but 
Ssc3 cannot fulfill all the functions of Ssc1 as it cannot complement the lethal ssc1∆ (99, 100).  Ssq1 
shares 52% identity to Ssc1, and while Ssc1 overexpression can rescue the growth phenotypes of 
ssq1∆ during cold stress, Ssq1 overexpression does not fix the translocation defects in cells expressing 
an Ssc1 mutant (101). Assembly of FeS clusters in mitochondria requires Ssq1 activity along with the 
Hsp40, Jac1 (102). In the mitochondrial matrix, yeast has an Hsp104 homolog known as Hsp78 which 
binds and stabilizes unfolded proteins to prevent aggregation (65, 77).  Hsp78 has chaperone 
functions that overlap with those of Ssc1 such as maintaining genome integrity and respiration in the 
mitochondrion and conferring mitochondrial thermotolerance (77). Hsp70 is conserved throughout 
various compartments of the yeast cells to promote protein folding in diverse environments in 
coordination with cochaperones that add specificity to the Hsp70 machine. 
 
Sse1/Hsp110 as a nucleotide exchange factor and holdase 
 
First characterized in 1993, the Sse1/Sse2 proteins share high similarity with each other (97%) 
and with the Hsp70 protein Ssa1 (70%) (71). Distinct from other NEFs, Hsp110 share similar structure 
to Hsp70 and are divergent members of the Hsp70 superfamily. Hsp110, like Hsp70 proteins, is 
composed of a nucleotide binding domain (NBD) with an ATP binding pocket, and a substrate binding 
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domain (SBD) at the C-terminus (103) (60) (104). The NBD is followed by a linker that connects it to 
the SBD which can be subdivided into a β-domain (β sandwich and loop) and a α-domain (Figure 1-1). 
The loop in the SBD β functions as a spacer region between the β-domain sandwich and α-helix 
bundle that makes up the α-domain (59). 
Unlike the Hsp70s, the NBDs of Sse1 and Sse2 bind ATP but hydrolysis is not required for their 
NEF activity (39, 44, 47, 105). ATP binding allows the Sse1 NBD to be in a proper conformation to 
interact with Hsp70. The Sse1 α-helical lid domain contacts the Hsp70 NBD in the heterodimer 
complex (Figure 1-3) (60, 104). The crystal structure for the Hsp70-Sse1 complex depicts two 
chaperones interacting primarily through the NBDs and the Hsp70 SBD in close proximity to the Sse1 
β-domain (104, 105). In complex, the Sse1 substrate binding domain remains exposed and potentially 
free to bind an unfolded polypeptide, suggesting possible cooperative substrate binding. Whereas the 
entire SBD of Hsp70 is known to bind regions of unfolded polypeptides and accelerate substrate 
folding (“foldase” activity), a cellular role for the Sse1/Sse2 β-domain has not been found but it is 
hypothesized to be a peptide-binding site (103). Sse1 and mammalian Hsp110 are capable of binding 
unfolded substrates and can act as a “holdase” in vitro, meaning that they can stabilize unfolded 
proteins independently of Hsp70 (106-108). Sse1 exhibits a preference for regions rich in aromatic 
residues that differ from the aliphatic residues commonly bound by Hsp70 (30, 109). The ability of 
Hsp110/Sse1 to bind unfolded polypeptides in vitro, the unique peptide preference, and the 
conformation of the heterodimer complex with Hsp70 suggest the possibility that Sse1 and other 
Hsp110s interact with substrate during the Hsp70 folding cycle. It is widely accepted that Hsp110 
modulates Hsp70 function through involvement in its ATPase cycle, but it remains disputed if Hsp110 
additionally influences Hsp70 substrate targeting. Biochemical studies have implicated the human 
Hsp110 as the single NEF that can power a metazoan dissaggregase machine (110-112). Together, 
these data support a model wherein Sse1 binds substrate using its SBD to stabilize unfolded proteins 
in vivo thus contributing to Hsp70-mediated protein folding by function other than NEF activity.  
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Figure 1-3. Crystal structure of Hsc70-Hsp110 complex. Ribbon model of the heterodimer where 
Hsp110 is colored in red, yellow, orange, and brown, and Hsp70 is colored in blue tones (104). This 
figure was obtained from Schuermann, J. P., J. Jiang, J. Cuellar, O. Llorca, L. Wang, L. E. Gimenez, S. Jin, 
A. B. Taylor, B. Demeler, K. A. Morano, P. J. Hart, J. M. Valpuesta, E. M. Lafer, and R. Sousa. 2008. 
Structure of the Hsp110:Hsc70 nucleotide exchange machine. Mol Cell 31: 232-243. It was printed 
with permission from Elsevier, the owner of Molecular Cell, through license number 4077501097759.  
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Sse1 is an abundant and potent Hsp70 NEF that is constitutively expressed, and both SSE1 and 
SSE2 are transcriptionally upregulated during stress conditions  (113). During heat stress, SSE1 is 
upregulated approximately two-fold, and SSE2 transcripts increase by up to twelve-fold (71). Deletion 
of SSE1 confers a distinct growth deficiency and a temperature sensitive phenotype, whereas a 
combined deletion of non-essential SSE1 and SSE2 is lethal (40, 44, 71). The overexpression of the 
cytosolic Snl1∆N or Fes1 NEFs can partially rescue the growth phenotype of sse1∆ cells grown under 
optimal conditions but cannot complement the nonviable sse1∆sse2∆ (114, 115). These phenotypes 
indicate that Sse proteins perform a unique cellular role that other cytosolic NEFs cannot fulfill. Given 
that Sse proteins are unique in their ability to bind unfolded polypeptides, it stands to reason that 
their substrate binding functions cannot be rescued by the other cytosolic NEFs.  
 
Biomedical Significance  
 
The chaperone system that coordinates protein quality control during environmental stress 
also overcomes the folding barriers so proteins encoded by genes with mutations can properly fold 
(116). Protein misfolding and aggregation are linked to many human diseases. Neurodegenerative 
disorders such as Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s (HD) disease, and Amyotrophic 
Lateral Sclerosis (ALS) are examples of the deleterious effects of protein misfolding and aggregation 
(116, 117). AD, HD, ALS and PD are essentially diseases where misfolded proteins form fibrillar 
aggregates that are deposited around neurons. Alzheimer’s disease is characterized by amyloid 
plaques or neurofibrillary tangles caused by Aβ-peptide or Tau respectively (118) . Lewy body 
formations of α-synuclein are commonly found in Parkinson’s disease (3, 118).  When the huntingtin 
(Htt) protein is mutated with an expansion of CAG repeats that code for polyglutamine stretches, 
intracellular inclusion and cytoplasmic aggregates can form to cause the progression of Huntington’s 
Disease (118, 119). Patients with ALS have neuronal aggregates formed by various mutant proteins 
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some of which are the mutant superoxide dismutase (SOD1) or fused-in-sarcoma (FUS) gene  (118, 
120-122). Common to all of these diseases is the neuronal impairment that protein misfolding causes 
due to cytotoxicity, the age-dependent onset of the disorders, and the eventually fatal course in 
patients.   
Animal models are currently being used to further our understanding of the molecular 
mechanisms that drive these diseases. Stress responses and molecular chaperones, specifically 
Hsp110, are potent modifiers of protein aggregation and can alleviate the degenerative effects of the 
“gain-of function” toxic species that cause disease (28). In mice, the absence of one of the three 
Hsp110 homologs results in accumulation of the toxic hyperphosphorylated form of tau and enhanced 
neurodegeneration (123). Furthermore, Hsp110 has proved to be highly effective at preventing 
degeneration and toxicity in flies and mammalian cells expressing polyglutamine proteins (124-126). 
Similarly, nematodes expressing a mutant human SOD1 demonstrated diminished locomotion and 
aggregate accumulation when Hsp110 levels were reduced through RNAi knockdown (127). Hsp110 
also localizes with aggregates of polyglutamine proteins and SOD1 mutants in vivo (124, 127). As yet, 
the functional role of the Hsp110 β domain in the Hsp70 protein folding process and the physiological 
implications of this activity remain unknown.  
The work presented here addresses long-standing questions in molecular chaperone research 
and expands our understanding of molecular chaperones. It characterizes Hsp110/Sse1, a 
cochaperone that is required for function of the ubiquitous Hsp70, through biochemical and genetic 
experiments using yeast and fruit fly chaperones. Chapter 3 describes a novel, micro-scale, and semi-
automated method to characterize the molecular dynamics of different types of protein complexes in 
vitro using a microplate reader. The interactions between Sse1 and unfolded polypeptides and the 
physiological implications of this chaperone activity are investigated in chapter 4. Here, I tested the 
involvement of Sse1 substrate binding with respect to growth, proteome maintenance, stress 
response, Hsp90-mediated activities, and in clearing fatally misfolded proteins. A regulated 
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fluorescence affinity (RFA) tag was used to investigate Sse1 roles in maintaining cellular proteostasis 
as detailed in chapter 5. Finally, Chapter 6 establishes the biochemical characterization of the 
Drosophila melanogaster Hsp110 which can be later utilized to investigate the molecular dynamics in 
a huntingtin (Htt with polyglutamine expansions) model of disease. 
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Chapter 2: Materials and methods 
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Strains, Plasmids and Yeast Culture  
All yeast strains are derived from either BY4741 or W303 (Table 2-1). Mutant sse1sbd was 
constructed via site directed mutagenesis by PCR using the plasmid p413TEF-FLAG-SSE1 as a template. 
This SSE1 allele and the sse1nbd mutant (sse1-G233D, previously described in (128)) were sub-cloned 
into the p413TEF vector using SpeI/XhoI restriction sites (129). The plasmids p413TEF-FLAG-SSE1-RFA 
and p413TEF-FLAG-RFA were constructed by Julie Heffler (130) .  The Hsc70cb (Drosophila 
melanogaster Hsp110) gene was PCR amplified from the plasmid pUAST-Hsc70cb (kind gift from Dr. 
Sheng Zhang, UTHealth) and cloned into p413TEF using XbaI/SpeI.  
For immunoprecipitation experiments, SSE1 alleles were expressed from the p413TEF 
plasmid. A FLAG epitope tag (DYKDDDDK) was added to the 5’ end of the SSE1 or Hsc70cb genes 
immediately after the start codon by using primers that included the FLAG-encoding, yeast-optimized 
sequence (5’-GACTACAAGGACGACGATGACAAAATG-3’).  
Strains expressing the various SSE1 alleles from the endogenous locus (YPL106C) were 
constructed by gene replacement (Figure 2-1.A). SSE1 amplicons were generated from plasmids 
containing a CYC1 terminator sequence using primers (5’-ATAACTCTGTCCTTGCCGT-3’) and (5’- 
TACTCTGTCAGAAACGGCCTGTACCGGCCGCAAATTAAAGCC-3’) to PCR-amplify from nucleotide +35 
relative to the ATG in SSE1 (forward primer) to the 3’ end of the CYC1 terminator and including an 
overhang with homology to the LEU2 terminator (reverse primer). The LEU2 cassette was PCR-
amplified from plasmid DNA using a forward primer that shares homology with the CYC1 terminator 
(5’-GCTTTAATTTGCGGCCGGTACAGGCCGTTTCTGACAGAGTAAAATTCTTG-3’) and a reverse primer with 
an overhang that shares homology with the endogenous SSE1 terminator (5’- 
AATCTTTTTTTAACTATACAGAGAAGATATTAGTATTTCACACCGCATATCG-3’). The two PCR amplicons 
were co-transformed into the BY4741 parent strain and successful Leu+ double recombinants were 
selected. Individual clones were obtained, verified by PCR amplification of the SSE1-LEU2 junction and 
an area internal to SSE1 using genomic DNA, verified by Western blot, and sequenced to ascertain 
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correct integration, presence of desired mutations, and absence of additional nucleotide substitutions 
(Figure 2-1.B and C).  
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Figure 2-1. Allele recombination to produce Sse1 variant strains. A. Allele exchange for SSE1 variants 
including areas of homology between recombinant fragments and genomic DNA in orange, green, and 
blue. B. Verification of proper insertion of SSE1 and LEU2 into the yeast genome by PCR1 and PCR2 as 
depicted in (A). C. Verification of protein production and proper protein length by immunoblotting 
with anti-Sse1 antiserum. 
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Table 2-1. Strains used in these studies. 
strain and genotype source 
BY4741 MATa ura3Δ leu2Δ his3Δ met15Δ Open Biosystems 
BY4741 sse1∆::kanMX [Abrams 2014] 
BY4741 SSE1:LEU2 this study 
BY4741 SSE1nbd:LEU2 this study 
BY4741 SSE1sbd:LEU2 this study 
BY4741 SSE1:LEU2 sse2∆:: kanMX Unekwu Yakubu 
BY4741 SSE1nbd:LEU2 sse2∆:: kanMX Unekwu Yakubu 
BY4741 SSE1sbd:LEU2 sse2∆:: kanMX Unekwu Yakubu 
BY4741 SSE1-RFA:LEU2 sse2∆:: kanMX Unekwu Yakubu 
W303 MATa ura3-52 trp1 leu2-3,112 his3-11,15 ade2-1 can1-100 [Rothstein 1991] 
W303 sse1∆::kanMX sse2∆:: LEU2 [Trott 2005] 
BY4741 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 sse1∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1nbd:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1sbd:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1-RFA:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1nbd:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
BY4741 SSE1sbd:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3) this study 
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Table 2-2. Plasmids used in these studies. 
plasmid source 
pSSA3-lacZ, URA3-based expression plasmid, GPD promoter [Liu 1999] 
pCH-FLAG-RatGR, HIS3-based expression plasmid [Liu 1999] 
pYRP-G2, 2 µ URA3-based expression GRE-lacZ reporter [Liu 1999] 
p413TEF, HIS3-based expression plasmid, TEF promoter [Mumberg 1995] 
p413TEF-FLAG-SSE1, HIS3-based expression plasmid, TEF promoter [Abrams 2014] 
p413TEF-FLAG-SSE1nbd, HIS3-based expression plasmid, TEF promoter [Shaner 2004] 
p413TEF-FLAG-SSE1sbd, HIS3-based expression plasmid, TEF promoter this study 
p413TEF-FLAG-SSE1-RFA, HIS3-based expression plasmid, TEF promoter Julie Heffler 
p413TEF-FLAG-Hsc70cb, HIS3-based expression plasmid, TEF promoter this study 
pProEX-Htb-HIS6-SSE1, inducible bacterial expression plasmid this study 
pProEX-Htb-HIS6-SSE1sbd, inducible bacterial expression plasmid this study 
pProEX-Htb-HIS6-SSE-RFA, inducible bacterial expression plasmid this study 
pProEX-Hta-HIS6-Hsc70cb, inducible bacterial expression plasmid this study 
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Hsf1 activity was measured with strains harboring plasmid pSSA3HSE-lacZ as described (131, 
132). For experiments testing CPYǂ-GFP degradation, strains were constructed using pRH2081 
(generous gift from Dr. Randy Hampton, University of California, San Diego), a plasmid that carries 
TDH3-driven CPY‡-GFP (133). The integrative plasmid was linearized using restriction endonuclease 
Van91I and transformed into indicated strains with Ura+ selection.  
To assess growth and complementation, cells were spotted on appropriate solid medium with 
a starting concentration of OD600=1.0 and serially diluted 1 in 10. Cultures were incubated at 15, 30, 
34, 37, 39 ᵒC, or in the presence of chemical compounds (formamide or trimethoprim) for 2-4 days at 
which point plates were photographed.  
Cells were grown at 30 ᵒC at a starting OD600 of 0.05 with shaking while absorbance readings 
were detected every 15 minutes using a Synergy MX Microplate Reader (BioTek). Doubling time was 
calculated by plotting data points from a 16-hour growth curve. GraphPad Prism v.6 (GraphPad 
Software, La Jolla, CA) was used to determine the doubling time based on the log phase growth of 
each culture using an exponential growth equation.  
 
Protein Purification 
Purified firefly luciferase (Sigma L-9506), citrate synthase (Sigma C-2360), and rhodanese 
(Sigma R1751) were obtained from Sigma Chemical Corp. (St. Louis, MO). Sse1 was purified from 
Escherichia coli BL21 (DE3) by metal affinity chromatography followed by size exclusion 
chromatography as described in (134). Hexa-histidine tagged Sse1 was purified from E. coli by 
chemical lysis (Bug Buster, Millipore) in buffer B (50 mM Tris pH 7.5, 200 mM NaCl, 2 mM MgCl2, 5 
mM imidazole). The cell lysate was incubated with His-Pur Cobalt Resin (Thermo Scientific), washed 
with buffer B and C (50 mM Tris pH 7.5, 600 mM NaCl, 2 mM MgCl2, 10 mM imidazole), and eluted 
with Buffer E (50mM Tris pH 7.5, 700 mM NaCl, 2 mM MgCl2, 200 mM imidazole). Sse1-containing 
elution fractions were combined, buffer exchanged (25 mM Tris pH 7.5, 100 mM NaCl), and further 
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purified by size exclusion chromatography using Sephacryl S-100 (GE Healthcare). Purification of 
Hsc70cb was performed following the same protocol as for Sse1.  
 
Nucleotide Binding Assay 
Fluorescently labeled nucleotide, N6-(6-Amino)hexyl-ATP-5-FAM (ATP-FAM) (provided by Dr. 
Jason Gestwicki; Jena Bioscience, Jena, Germany), was incubated at a concentration of 20 nM with 
increasing amounts of Sse1 or Sse1sbd chaperone in buffer (25 mM Tris-HCl, pH7.5, 100 mM NaCl, 5 
mM MgCl2, 50 mM KCl, 5% glycerol) for 30 minutes at room temperature as described (135). 
Fluorescence polarization was measured (excitation λ: 485 nm emission λ: 535 nm) using a 
SpectraMax M5 plate reader (Molecular Devices). Equilibrium binding constants were calculated using 
a saturation binding one-site equation via GraphPad Prism v.6 (GraphPad Software, La Jolla, CA). 
These experiments were conducted in the laboratory of Dr. Jason Gestwicki (University of California 
San Francisco) with use of their equipment and reagents. 
 
Nucleotide Exchange Assay 
The HSPA8 (Hsc70) protein was a generous gift from Dr. Betty Craig (University of Wisconsin, 
WI). HSPA8 (70 µg) was loaded with 100 µCi of α-32P-ATP in a total volume of 120 µL of complex 
buffer (25 mM HEPES-KOH pH 7.5, 100 mM KCl, 11 mM MgOAc, and 25 µM ATP) for 30 minutes at 4 
°C, and HSPA8-32P-ATP complex was obtained by centrifugation through a Microspin G-25 column (GE 
Healthcare, Chicago, IL). Labeled HSPA8 (7.8 µg) was incubated in the presence or absence of 5 µg of 
NEF at 30 °C. At designated times, the HSPA8-NEF reactions were again passed over G-25 columns to 
separate from released nucleotide. Radiolabeled nucleotide that remained bound to HSPA8 was 
determined using a TRI-CARB 2900TR Liquid Scintillation Analyzer and normalized to counts obtained 
at time zero. 
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Protein Aggregation Assay 
Aggregation assays were conducted in a Synergy MX Microplate Reader. Rhodanese and 
citrate synthase were incubated in denaturing buffer (6 M guanidinium chloride, 5 mM dithiothreitol) 
at concentrations of 13.3 and 11.6 uM, respectively for 1 hour at room temperature (136) (137) (138). 
Refolding buffer (25 mM Tris pH 7.5, 100 mM NaCl) or denaturing buffer (6 M guanidinium chloride, 5 
mM dithiothreitol) were pre-equilibrated at 25 °C in a 96-well, half area, UV-transmissible plate 
(675801, Greiner Bio-One) for 5 min and baseline absorbance was determined.  After equilibration, 
chemically denatured substrate was added to a final concentration of 150, 300, 600, or 900 nM into 
the refolding buffer or 900 nM into the denaturing buffer to a final volume of 180 µL. The samples 
were mixed thoroughly and absorbance was measured at 320 nm at 30-second intervals for 30 
minutes. Changes in absorbance were calculated after subtracting baseline absorbance at time zero, 
and all experiments with a given substrate were performed concurrently on a single microplate. 
To compare chaperone capabilities of Sse1, Sse1sbd, or Hsc70cb, substrate aggregation was 
measured as described in (134) with the following modifications. Stock concentrations of firefly 
luciferase or citrate synthase were incubated in denaturing buffer for 1 hour at room temperature. In 
a 96 well, half area, UV-transmissible plate refolding buffer alone, varying concentrations of 
chaperone in refolding buffer, or denaturing buffer were pre-equilibrated at 25 °C for 5 minutes and 
baseline light scattering was determined. After equilibration, chemically denatured substrate was 
added to each sample at a final concentration of 200 nM into the refolding buffer to a final volume of 
180 µL. The samples were mixed vigorously for 5 seconds and aggregation was measured at 320 nm at 
30-second intervals for 30 minutes. Changes in absorbance were calculated after subtracting baseline 
absorbance at time zero.  
To assess fractionation of protein into soluble and insoluble aggregates, samples (175 µL) 
were taken from the endpoint of the substrate aggregation experiments and subject to centrifugation 
at 16,000 x g for 4 minutes. 170 µL were recovered as the supernatant or soluble fraction. The lower 5 
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µL fraction was considered the pellet or insoluble fraction and volume was normalized to 170 µL with 
the addition of refolding buffer. 30 µL of each fraction were separated by 12% SDS-PAGE and stained 
with Coommassie Blue. Band densities were calculated using Image Studio Software (Li-Cor 
Biosciences, Lincoln, NE). 
 
Immunoblotting 
Cultures were grown overnight and secondary cultures started and allowed to grow to an 
OD600 of 0.8 at which point cells were shifted to 37 °C or maintained at 30 °C for 6 hours. Cells were 
collected and processed for protein lysates. Sse1 protein levels were detected by immunoblot using 
anti-Sse1 antiserum (generous gift from Dr. Jeff Brodsky, University of Pittsburgh, PA) and anti-
phosphoglycerate kinase (PGK; Invitrogen, Carlsbad, CA) was used as a loading control. Band analysis 
was performed using Image Studio Software and Sse1 levels were normalized to the levels of PGK. 
Hsp90 levels in were assessed in cells grown at  30 °C by immunoblot using anti-Hsp90 (generous gift 
from Dr. Avrom Caplan, CUNY, NY) with anti-Sse1 and anti-PGK as internal controls. Band analysis was 
performed using Image Studio Software. Sse1 and Hsp90 levels were normalized to PGK levels. 
 
Immunoprecipitations 
Sse1 proteins were expressed with an N-terminal FLAG-tag. Protein extracts were prepared 
from 30 mL of cultures grown at 30 °C or 37 °C for 6 hours. Protein lysates were incubated with 40 µL 
of M2 resin (Sigma) in TEGN (20 mM Tris-HCl, pH 7.9, 0.5 mM EDTA, 10% glycerol, 50 mM NaCl) at 4 
°C for two hours. After washing with 4 mL of buffer, the resin was incubated with 40 µL of FLAG 
peptide for 25 minutes at room temperature to elute the FLAG-Sse1 complexes. Immunoprecipitated 
proteins were analyzed by SDS-PAGE and Coommassie Stain. Band analysis was performed using 
Image Studio Software and the co-immunoprecipitation efficiency of Hsp70 was calculated relative to 
the amount of Sse1 immunoprecipitated.  
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The GFP immunoprecipitation was performed using Sepharose beads conjugated with anti-
GFP monoclonal antibody. Protein lysates from 35 mL of cells at log phase were obtained and 
incubated with anti-GFP (Thermo Fisher Scientific Inc., Waltham, Massachusetts) in buffer (TEGN, 
protease inhibitor, 0.1% Triton X-100). The protein lysate/antibody solution was incubated with 
protein A sepharose (Sigma-Aldrich, St. Louis, MO) followed by washing. Immunoprecipitated proteins 
were eluted in 40 µL Laemmli sample buffer at 80ᵒ C. Samples were visualized by SDS-PAGE and 
Coommassie Stain.  
 
Glucocorticoid Receptor Activation 
The various Sse1 strains were transformed with plasmids pCH-Flag-RatGR and pYRP-G2 
expressing the glucocorticoid receptor protein and a GRE-lacZ transcriptional reporter, respectively 
(131). Cells grown to mid-logarithmic phase were treated with DMSO only (-DOC) or 10 µM 
deoxycorticosterone in DMSO (+ DOC) for 1.5 hours. β-galactosidase activity was measured by adding 
50 µL of cell suspension at OD600 0.4 and 50 µL of Beta-Glo reagent (Promega, Madison, WI) and 
incubating for 30 minutes at 30 °C followed by luminescence detection using a Synergy MX Microplate 
Reader.  
 
CPYǂ-GFP Degradation Assay 
To track the degradation of the CPYǂ-GFP protein in vivo, cells were grown to mid-logarithmic 
phase, treated with 100 µg/mL cycloheximide, and 10 mL of culture were collected at 0, 1, and 2 
hours. Denatured protein extracts were prepared using a glass bead lysis method with SUME buffer 
(1% SDS, 8M Urea, 10mM MOPS, pH 6.8, 10mM EDTA). The CPYǂ-GFP protein was detected by 
immunoblot using anti-GFP (Roche, Basel, Switzerland) and anti-PGK was used an internal control. In 
parallel experiments, CPYǂ-GFP-expressing cells were collected immediately after treatment at 0, 45, 
and 90 minutes and visualized using an Olympus IX81-ZDC inverted microscope as described in (14).  
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The experiments to assess CPYǂ-GFP aggregates in the SSE1-RFA strain were conducted by 
growing the different strains in the absence or presence of 500 µM trimethoprim for 6 hours or more. 
When the cells reached log phase, they were treated with cycloheximide and cells were analyzed via 
immunoblot or by microscopy at the times indicated.   
 
Protein similarity analysis 
  Hsc70cb and Sse1 were compared to determine protein similarity using the NCBI protein 
blast software. For the Hsc70cb query, the protein sequence used was Hsc70Cb (isoform A) obtained 
from uniprot.org (http://www.uniprot.org/uniprot/Q9VUC1). The Sse1 (YPL106C) amino acid 
sequence was obtained from the Saccharomyces Genome Database using reference strain S288C 
(http://www.yeastgenome.org/locus/S000006027/protein).  
 
Statistics 
 The data represented in the graphs is the mean of independent replicates and the error bars 
represent ± standard deviation. Statistical analysis was performed using a student’s t-test.  
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Chapter 3: Semi-automated microplate monitoring of protein polymerization and aggregation 
 
 
 
 
 
 
 
 
 
 
Note: This chapter was derived from work that is published in the Journal of Analytical Biochemistry. 
Garcia VM, Rowlett VW, Margolin W, Morano KA. Semi-automated microplate monitoring of protein 
polymerization and aggregation. Anal. Biochem. 2016 Sept. 508: 9-11. I acquired the data presented 
in this chapter. FtsZ polymerization experiments were performed by Veronica Rowlett, Ph.D., in 
collaboration with the laboratory of William Margolin, Ph.D. These data are thus excluded from this 
chapter. Permission to use previously published material was granted by Elsevier, owner of Analytical 
Biochemistry, through license number 4063260221106. 
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Introduction 
 
Static light scattering (SLS) techniques such as multi-angle (MALS) and right-angle (RALS) 
measure the light deflected from particles in solution that are larger than the wavelength of the light 
emitted. Such methods typically require expensive fluorimetry equipment, consume large amounts of 
purified protein, and may be unsuitable for high-throughput assays (136, 139). For example, a 
fluorimeter equipped with a stirrable, temperature-controlled cell holder is required for RALS analysis, 
and the cost of such equipment may be prohibitive for many laboratories. Furthermore, such devices 
are limited to single cell measurements, and the need to maintain solution homogeneity through 
mechanical stirring dictates mL-scale volumes per experiment. If proteins are tested at nano- or 
micromolar concentrations, significant amounts of purified or purchased proteins are required.   
 Described here is an alternative method for tracking the formation of aggregates of proteins 
that yields results comparable to SLS. This approach utilizes a microplate reader with temperature 
control, along with 96-well half area microplates that allow for multiple reactions to be analyzed 
simultaneously in a low reaction volume. While previous applications of microplate technology for 
following protein dynamics in high-throughput molecular screens have been described (66, 140, 141), 
I demonstrate here the sensitivity and range of this technique by measuring protein aggregation of 
three traditional chaperone substrates and aggregate prevention by a molecular chaperone. The 
method described here measures, in real-time, the increase in turbidity that occurs as high molecular 
weight protein complexes or aggregates form in an aqueous buffer. Our overall goal was to show that 
a method for sensitive, rapid and reproducible comparative monitoring of protein assembly dynamics 
in small volumes can be accessible to molecular biologists. 
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Results 
 
 Various biological applications require the study of large protein complexes. For example, 
tracking the formation of aggregates allows the characterization of molecular chaperones. By 
monitoring the aggregation of model substrates in the presence of chaperones, we can understand 
the substrate specificity, molecular dynamics, and environmental requirements for chaperone 
function. Traditionally, methods like MALS or RALS are utilized to detect dynamics of aggregate 
formation and chaperone activity. A sample is placed in the path of emitted light, and these 
techniques directly measure light that is scattered at multiple designated angles for MALS or at a right 
angle from the light source in the case of RALS. While these methods can produce a lot of information 
about the given sample, such as the absolute molar mass or average molecular size of the molecules 
in the solution, the instruments required to conduct this type of analysis are expensive and not widely 
available. Initially, I characterized protein aggregation and chaperone activity using RALS but the 
requirement of large volumes of protein at high concentrations became prohibitive (equipment 
provided by the laboratory of Dr. Vasanthi Jayaraman, UTHealth). The alternative method I describe 
here can track the formation of aggregates by measuring absorbance. The reduction in light 
transmittance is detected as aggregates increase and grow in a solution (Figure 3-1.A). Aggregation is 
monitored in real time, using smaller protein volumes, and across multiple samples concurrently. 
Chaperones detect unfolded proteins and prevent their aggregation by stabilizing unfolded 
polypeptides until native conformations are achieved (5). Chaperones differ in substrate specificity 
and their molecular interactions with clients, and various aggregation-prone model proteins including 
firefly luciferase, rhodanese, and citrate synthase have been used to elucidate biochemical features of 
chaperone function and specificity (107, 137, 142-144). Due to the irreversible side reactions that 
occur during unfolding, these, and other commonly employed substrates, rapidly aggregate when 
diluted from a denaturing solution into a non-denaturing buffer unless accompanied by molecular 
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chaperones (138, 145). Firefly luciferase was chemically denatured (denaturing buffer: 6 M 
guanidinium chloride, 5 mM dithiothreitol) and diluted into the refolding buffer (25 mM Tris pH 7.5, 
100 mM NaCl) or denaturing buffer. The samples were mixed thoroughly while making sure to not 
introduce air bubbles and transmittance was measured at 320 nm at 30 second intervals for 45 
minutes at 25 ᵒC. Changes in transmittance were calculated after subtracting baseline transmittance 
at time zero. Figure 3-1.B demonstrates that denatured firefly luciferase remains denatured in the 
presence of guanidinium chloride and that aggregation can be detected in the refolding buffer. As an 
alternative approach, the samples that were monitored during the aggregation experiments were 
collected and centrifuged to isolate the soluble firefly luciferase and the insoluble substrate 
aggregates into the supernatant and pellet respectively (106). This technique served to confirm that 
the increase in absorbance that was detected for the firefly luciferase in refolding buffer was due to 
substrate aggregation. Notably, transmittance changes due to the aggregation of firefly luciferase 
correlated with high-speed fractionation of the substrate into soluble (supernatant) and insoluble 
fractions (pellet) (Figure 3-1.C). Also, the firefly luciferase diluted further into denaturing buffer did 
not track an increase in transmittance and remained soluble, likely as monomers, as indicated by the 
differential centrifugation.  
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Figure 3-1. Monitoring aggregation of firefly luciferase. A. Aggregates are monitored through a 
decrease in light transmittance. B. Aggregation of 200 nM chemically denatured firefly luciferase (FFL) 
is monitored in denaturing buffer (DC) or refolding buffer (AC). Average data points are plotted (n=4) 
with a standard deviation ≤ 0.003. C. One representative image of an SDS-PAGE gel and Coommassie 
stain visualizing the fractionation of soluble (S) or aggregated (P) FFL by centrifugation after 30 
minutes.  
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The aggregation of chemically denatured rhodanese and citrate synthase was monitored at 
various concentrations (136-138). Refolding buffer or denaturing buffer were pre-equilibrated at 25°C 
in a 96-well, half area plate for 5 min and baseline transmittance was determined.  After equilibration, 
denatured substrate was added to a final concentration of 150, 300, 600, or 900 nM into the refolding 
buffer or 900 nM into the denaturing buffer and transmittance was measured at 320 nm at 30 second 
intervals for 30 minutes. Changes in transmittance were calculated after subtracting baseline 
absorbance at time zero, and all experiments with a given substrate were performed concurrently on 
a single microplate. Denatured rhodanese aggregation was tracked by measuring absorbance at 320 
nm (Figure 3-1. B). Our results indicate that this method successfully detects increasing aggregation 
over time, using concentrations of denatured rhodanese in line with those previously published (136, 
144).  Similarly, the results obtained using chemically denatured citrate synthase were similar to those 
previously published (106, 143). Aggregates formed by either substrate were detected at 
concentrations as low as 150 nM and the change in transmittance increased with greater substrate 
concentrations, consistent with increased light scattering due to the formation of aggregates (Figure 
3-2. B).   
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Figure 3-2. Aggregation of model chaperone substrates rhodanese and citrate synthase. A. 
Rhodanese was denatured in 6 M guanidinium chloride + 5 mM DTT for 45 minutes. Denatured 
rhodanese was diluted into 180 µL of assay buffer (25 mM TRIS pH7.5 + 100 mM NaCl) and 
aggregation was measured at 25 °C by change in absorbance using a Biotek Synergy MX plate reader. 
Average data points are plotted (n=4) with a standard deviation ≤ 0.003. B. The aggregation of citrate 
synthase was measure using the same method as for rhodanese. Average data points are plotted 
(n=2) with a standard deviation ≤ 0.003. 
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I assessed whether this microplate reader assay would be adaptable to study the ability of 
molecular chaperones to modulate protein aggregation. Molecular chaperones help to maintain 
cellular proteomes by interacting with unfolded or partially folded proteins, preventing their 
aggregation and stabilizing polypeptides until native conformations are achieved (3). Citrate synthase 
is recognized as a substrate by the Hsp110 class of chaperones that stabilize the unfolded protein to 
prevent aggregation (142, 146). I analyzed the aggregation dynamics of citrate synthase in the 
presence of the yeast Hsp110 chaperone, Sse1. Hexa-histidine tagged Sse1 was purified from 
Escherichia coli and used for analysis of protein aggregates in the presence of a chaperone. The 
protein solutions must be equilibrated to the temperature and buffer conditions of the assay, as an 
abrupt shift in buffers or temperature can result in an artificial increase in absorbance. Each sample 
was equilibrated in refolding buffer with 0, 100, 200, 400, or 800 nM Sse1 or denaturing buffer in the 
absence of Sse1 at 25° C in a 96-well, half area plate for 5 min while absorbance was measured. After 
equilibration, chemically denatured citrate synthase was added to 200 nM, chosen as a minimal 
aggregating substrate concentration, into the refolding buffer or into the denaturing buffer, with and 
without Sse1, to a final volume of 180 µL. The samples were mixed thoroughly for 5 sec and 
absorbance was measured at 320 nm every 30 sec for 30 min at 25°C. Consistent with reported 
results, increasing Sse1 concentrations promote solubility of the aggregate-prone substrate (Figure 3-
3. A). Notably, absorbance changes due to the aggregation of citrate synthase correlated with transfer 
of the substrate from a high-speed sedimentable fraction to a soluble state as assessed by SDS-PAGE 
of endpoint samples followed by Coommassie Blue staining (Figure 3-3. B). 
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Figure 3-3. Monitoring aggregate prevention of citrate synthase and protection by Sse1. A. Citrate 
synthase (CS) was denatured same as described and diluted into assay buffer with increasing 
concentrations of chaperone. Average data points are plotted (n=3) with a standard deviation ≤ 0.003. 
B. Samples were collected from the end point of experiment in (A) and the soluble and aggregated 
fractions of CS and Sse1 were separated into supernatant and pellet through differential 
centrifugation followed by analysis on SDS-PAGE and Coommassie stain. 
 
Discussion 
A 
B 
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I have described an accessible, low- to high-throughput alternative to SLS that provides similar 
results at levels of detection comparable to single-cell analysis. In this work, I have demonstrated the 
applicability of this method to study the aggregation of three different model substrates that are 
routinely used to characterize chaperone activity (firefly luciferase, citrate synthase, and rhodanese). 
The method I presented has some limitations when compared with traditional MALS or RALS. It 
should be noted that a few seconds of data are lost during insertion and calibration of the plate when 
using a plate reader, making this technique unsuitable for analysis of initial burst dynamics. However, 
kinetic analyses to determine aggregation parameters may be undertaken using standard calculations 
(147). Further, the method adaptation I describe cannot provide information about molecular weight 
or size of the aggregates.  Nonetheless, the technique presented here is a simpler, quicker, and more 
efficient way to simultaneously compare the dynamics of high molecular weight protein assemblies 
across multiple samples and conditions. As microplate readers can be outfitted with both injection 
systems and ambient temperature controls, this approach can allow for concurrent analysis of 
multiple experimental variables. 
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Chapter 4: Substrate binding by the yeast Hsp110 nucleotide exchange factor and molecular 
chaperone, Sse1, is not obligate for its biological activities 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: This chapter was derived from work performed by Veronica Margarita Garcia. The data 
discussed regarding the refolding and disaggregating capacity of Sse1 and Sse1sbd is the work of 
Nadinath Nillegoda, Ph.D.  with recombinant Sse1 proteins supplied by Garcia, as a collaborative 
effort with the laboratory of Bernd Bukau, Ph.D. Because this work was not performed by Garcia, the 
data have been excluded.  
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Introduction 
 
Proteins must fold into a proper three-dimensional configuration, or native state, to execute 
their intended functions. Proteomic stressors such as exposure to harmful chemicals, oxidative stress, 
and aging can inhibit protein folding, disrupt protein homeostasis and result in cell death and human 
disease (3). Misfolded proteins or amyloid aggregates contribute to the development or progression 
of neurodegenerative disorders; Alzheimer’s disease, Huntington’s disease and Parkinson’s disease 
are all fundamentally diseases of protein misfolding (116, 120). Cell survival during and after stress 
conditions is promoted by molecular chaperones that optimize protein folding by stabilizing folding 
intermediates until native conformations have been obtained. The highly conserved Hsp70 chaperone 
is integral to protein biogenesis, quality control, and degradation of terminally misfolded proteins 
(53). The Hsp70 protein folding cycle is ATP-dependent and is regulated by co-chaperones such as 
Hsp40s and nucleotide exchange factors (NEFs) that stimulate ATP hydrolysis and exchange, 
respectively (148, 149). The budding yeast Saccharomyces cerevisiae expresses three classes of 
cytosolic NEFs all with human orthologs: the Hsp110-type proteins Sse1/Sse2, the HSPBP1-type 
protein Fes1 and the BAG-1-type protein Snl1 (150). SSE1 deletion results in slow growth and 
temperature sensitivity, whereas a combined deletion of SSE1 and SSE2 is lethal despite the presence 
of Fes1 and Snl1, suggesting a potentially unique role for the Hsp110 proteins (151, 152). The Hsp110 
proteins are highly homologous to Hsp70 composed of an amino-terminal nucleotide binding domain 
(NBD) and a substrate binding domain (SBD) that is further subdivided into a β-sandwich domain and 
an α-helical “lid” domain (59, 60, 104). Distinct from Hsp70, Sse1/2 bind ATP which stabilizes the NBD, 
but catalytic activity (ATP hydrolysis) is not required to functionally complement the null mutant in 
vivo or to accelerate Hsp70 nucleotide exchange in vitro (40, 44, 45, 47, 112). 
While the NEF function of Hsp110/Sse is well established, possible biological roles for 
substrate binding by the SBD remain speculative. Crystal structures of the Hsp70-Sse1 complex depict 
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the Hsp70 SBD in close proximity to the Sse1 β-domain, suggesting possible cooperative substrate 
binding (60, 104). The Hsp110 SBD is structurally similar, but not identical, to that of Hsp70, and it is 
suggested that it binds peptides much like Hsp70 through interactions with both β-sheets and the 
connecting loops within the β-domain (106-108). Hsp110s are highly efficient at blocking aggregation 
of misfolded substrates in vitro (defined as “holdase” activity) and Sse1 possesses a unique peptide 
binding preference for regions enriched in aromatic amino acids, relative to the yeast Hsp70, Ssa1 (30, 
109). While contributions to substrate selection and targeting to Hsp70 by Hsp40 co-chaperones are 
established, it remains unclear if the holdase activity of Sse1 or other Hsp110 chaperones contributes 
to Hsp70-dependent functions in vivo (57). Deletion mutagenesis to remove the Sse1 SBD is 
complicated by the fact that carboxyl-terminal deletions render the protein unstable, and that the α-
helical domain is required for heterodimerization with Hsp70  (44, 60, 104). Site-specific mutagenesis 
targeting residues in the Sse1 substrate binding domain modeled on the peptide binding site of the 
bacterial Hsp70, DnaK, was likewise unsuccessful (60). Yeast cells lacking Sse1 are defective in folding 
of newly synthesized polypeptides and degradation of some misfolded proteins (40, 132, 153). 
However, overexpression of either Fes1 or a soluble, truncated mutant form of the normally ER-
associated NEF Snl1, both of which lack demonstrated holdase activities, partially suppresses these 
phenotypes (39, 114). In contrast, other NEFs cannot substitute for Hsp110 in protein disaggregation 
reactions, suggesting that Hsp110 possesses specific properties that could be linked to its unique 
substrate binding domain (54, 110, 112, 154). 
In this study, I generated an Sse1 variant that separates, for the first time, the nucleotide 
exchange and substrate binding functions of this chaperone. Multiple targeted single-residue 
substitutions in the β-sandwich region of the SBD were introduced to generate a novel mutant 
(Sse1sbd) that exhibits greatly reduced aggregation-preventing activity while retaining nucleotide 
binding and Hsp70 nucleotide exchange potency. Strikingly, Sse1sbd was competent to restore growth 
to cells lacking SSE1 and/or SSE2, to promote disaggregase activity in a reconstituted in vitro system, 
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and to support Hsp70-dependent signal transduction and protein degradation while exhibiting minor 
defects in stress resistance and protein quality control. The data presented here suggest that the 
substrate binding function of Sse1, despite being conserved among the eukaryotic Hsp110 proteins, 
plays a minor role in maintaining protein homeostasis in the yeast system. 
 
Results 
 
I generated a novel Sse1 substrate binding domain (SBD) mutant based on previous structural 
studies (60, 109) that indicated the region mutated could be within a putative peptide binding site 
(Figure 4-1.A). This putative substrate binding defective mutant (Sse1sbd) includes four specific amino 
acid substitutions (L433A, N434P, F439L, and M441A) within the L3,4 region of the β-sandwich domain 
in Sse1. I first verified that the introduced mutations exclusively targeted substrate binding while 
maintaining proper nucleotide binding in the NBD. Recombinant proteins were purified from E. coli to 
conduct in vitro experiments (Figure 4-2). ATP binding was measured with fluorescently labeled 
nucleotide through fluorescence anisotropy. When compared to the wild-type protein, Sse1sbd bound 
FAM-ATP with approximately the same affinity (Kd of 12.1 µM ±1.9 for Sse1sbd, vs. 8.6 µM ±1.4 for 
wild-type Sse1, Figure 4-1.B). These values are consistent with previously reported affinities measured 
using a different fluorescently labeled nucleotide, MABA-ATP (2.1 µM ±0.6) (47). It was also essential 
that the mutant protein could still function as a nucleotide exchange factor (NEF) for Hsp70. I 
measured the exchange of α-32P-ATP loaded onto human Hsc70 (HSPA8) in the absence of NEF, or in 
the presence of Sse1 or Sse1sbd, and found no discernable difference in the accelerated exchange 
rates (Figure 4-1.C). Together these results demonstrate that Sse1sbd retains critical nucleotide-binding 
and NEF features of the Hsp110 chaperone. 
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Figure 4-1. Novel Sse1 substrate binding mutant retains Hsp70 nucleotide exchange capacity. A. 
Crystal structure of the Sse1 β-domain with amino acids selected for mutations highlighted in red 
(109). B. Fluorescence anisotropy was performed with increasing concentrations of chaperone (Sse1 
or Sse1sbd) binding fluorescently labeled ATP-FAM. (n=3) C. Nucleotide exchange activity assays using 
HSPA8 (Hsp70) pre-bound to α-32P-ATP in the presence or absence of Sse1 (n=2). Error bars in all 
panels indicate standard deviation. 
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Figure 4-2. Purification of recombinant Hexa-histidine tagged Sse1 proteins. A. Recombinant His-
Sse1 and His-Sse1sbd purified from E. coli visualized on an SDS-PAGE gel using Coommassie stain.  
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To assess whether substrate binding was impaired as predicted, I measured the ability of Sse1 
and Sse1sbd to prevent the aggregation of chemically denatured firefly luciferase (FFL) using an 
established assay system (134). Whereas wild-type Sse1 effectively reduced FFL aggregation relative 
to that observed in the absence of chaperone, the Sse1sbd protein was significantly impaired in 
aggregate prevention (Figure 4-3.A). To verify that the spectrophotometric assays reflected substrate 
aggregation into insoluble material, end-point samples were analyzed by differential centrifugation 
followed by SDS-PAGE and densitometry quantitation (Figure 4-3.B). Sse1 maintained 72% of FFL in a 
soluble state after 30 min, whereas only 39% of FFL is soluble in the presence of Sse1sbd as the 
chaperone. Similar results were obtained with citrate synthase as the unfolded substrate (Figure 4-
4.A-C). Increasing the ratio of Sse1 to FFL or CS allowed for better aggregate prevention, whereas 
increasing the ratio of Sse1sbd only mildly improved protection of the denatured substrate (Figure 4-
3.C and Figure 4-4.D). These data indicate the novel Sse1sbd mutant is defective in its ability to 
passively chaperone unfolded proteins while NEF function and nucleotide binding remain intact.  
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Figure 4-3. Sse1 substrate binding domain mutant exhibits impaired chaperone holdase activity 
towards firefly luciferase (FFL). A. Substrate aggregation experiments were conducted using 
chemically denatured firefly luciferase (FFL) (200 nM) diluted into refolding buffer without chaperone, 
with Sse1 (400 nM), or with Sse1sbd (400 nM). FFL diluted further into denaturing buffer was used as 
a control. B. Differential centrifugation analysis of FFL aggregation in the absence of chaperone or 
with Sse1 or Sse1sbd after a 30 min holdase assay. Samples were visualized by SDS-PAGE followed by 
Coommassie stain, and scanning densitometry quantitation was performed to determine FFL 
aggregation under each condition.  Graph represents the average FFL that remained soluble in each 
sample ± standard deviation (n=4) (p< 0.01). C. Analysis of holdase experiments using denatured FFL 
with varying ratios of chaperone were quantified using the endpoint degree of aggregation detected 
as in (B). Graph represents the average FFL that aggregated in each sample (n=2). Error bars represent 
± standard deviation (p< 0.05).  
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Figure 4-4. Sse1 substrate binding domain mutant exhibits impaired chaperone holdase activity 
towards citrate synthase (CS). A. Substrate aggregation experiments conducted using chemically 
denatured CS (200 nM) diluted into refolding buffer without chaperone, with Sse1 (200 nM), with 
Sse1sbd (200 nM), or with BSA (400 nM) as a non-chaperone control. B. Analysis of CS aggregation in 
the absence of chaperone in refolding or denaturing buffer or in the presence of different chaperones 
after 30 min in a holdase assay via differential centrifugation. Samples were analyzed via SDS-PAGE 
and Coommassie stain. C. Analysis of holdase experiments using denatured CS with varying ratios of 
chaperone using the endpoint amount of aggregation detected (n=2). Errors bars represent ± 
standard deviation. Data is not statistically significant between Sse1 and Sse1sbd. 
  
49 
 
Hsp110 however, when compared to other NEFs, has been demonstrated to boost the 
aggregate solubilization activity of the Hsp70-based disaggregase machine (54, 110, 154, 155). 
Nillegoda therefore tested if the substrate binding function of Sse1 is required in this capacity. As a 
first step, he tested if substrate binding by Sse1 was important for re-folding of thermally denatured 
monomeric FFL. FFL was heat denatured in the presence  of HSPA8 (Hsc70), DnaJB1 (Hsp40), and 
Hsp26 for 10 min at 42 °C (110). The samples were shifted to 30 °C and a nucleotide regeneration 
system was added. Refolding of FFL was measured in the presence of no NEF, Sse1, Sse1sbd, or HSPH2 
(human Hsp110) as a control. It has been previously established that yeast and human Hsp110s are 
functionally interchangeable (110). Sse1 and Sse1sbd were observed to aid Hsp70/Hsp40 equally in 
successful refolding of FFL (data not shown). To test if the substrate binding function of Sse1 might be 
necessary for the more difficult task of disaggregating FFL, aggregates were formed by FFL heat 
denaturation (15 min, 45 °C) in the presence of Hsp26, and the aggregates were mixed with a cocktail 
of chaperones containing HSPA8, DnaJB1, and no NEF, Sse1, Sse1sbd, or HSPH2. Again, substrate 
binding deficient mutant Sse1sbd functioned with Hsp70/Hsp40 as effectively as the wild-type Sse1 or 
the HSPH2 (human Hsp110) control (data not shown). All three Hsp110 proteins were able to 
reactivate over 40% of the aggregated FFL within the two-hour time course. The data indicate that 
Sse1 holdase activity is not obligatory for effective refolding or dissagregase activity of at least the 
model substrate FFL. 
Sse1 is a critical component of the protein quality control machineries. Indeed, sse1∆ cells 
demonstrate significant growth deficiencies including temperature sensitivity, and sse1∆sse2∆ cells 
are unviable (151). Furthermore, Sse1 and Sse2 are unique among known cytosolic NEFs for 
possessing substrate binding activity, raising the possibility that this activity is important in vivo. To 
test this hypothesis, I began by determining the expression of Sse1sbd to ensure that the introduced 
mutations did not affect its stability in vivo. At 30 °C and 37 °C, plasmid-borne Sse1, Sse1sbd and a 
previously described NEF-defective mutant carrying the G233D mutation (here designated Sse1nbd), 
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were expressed at similar levels, both slightly higher than endogenous Sse1 (Figure 4-5.A and B). I also 
wanted to ensure that Sse1sbd retained interaction with the yeast cytosolic Hsp70s (Ssa and Ssb) to 
function as a NEF in vivo. All Sse1 proteins were expressed with a FLAG-tag fused to the N-terminus 
and co-immunoprecipitations were performed (44). Sse1sbd was found to associate with the cytosolic 
Hsp70s, Ssa and Ssb, at both temperatures in a manner indistinguishable from wild-type Sse1 (Figure 
4-5.C and D).  
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Figure 4-5. Sse1sbd is stable and interacts with endogenous yeast Hsp70 proteins in vivo. A. Protein 
lysates from cells expressing the indicated SSE1 alleles and cultured at 30 °C or 37 °C were analyzed by 
immunoblot to determine expression levels and stability (n=3). B. Quantitative analysis of the 
immunoblots in (A). Error bars represent ± standard deviation.  C. Co-immunoprecipitation 
experiments using FLAG-tagged Sse1 (labeled with a closed circle) variants were performed to assess 
interactions with endogenous Ssa and Ssb proteins (labeled with an open circle) (n=3). Samples were 
analyzed via Coommassie stain on an SDS-PAGE. D. Quantitative analysis of band densities in (C). Error 
bars represent ± standard deviation. 
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Given that Sse1sbd displayed normal stability and retained Hsp70 interaction at both standard and 
heat shock temperatures, I next assessed the contribution of substrate binding to Sse1 functions in 
vivo. As previously mentioned, the sse1nbd allele contains the mutation G233D which renders it unable 
to bind nucleotide, interact with Hsp70, or act as a NEF (40, 44, 128). I compared the growth of sse1∆ 
cells expressing SSE1, sse1nbd, or sse1sbd under cold stress or heat stress. While sse1sbd fully 
complements sse1∆ cells grown in optimal conditions and under cold stress, the mutant allele could 
not confer normal growth under heat stress (Figure 4-6). This behavior contrasted with the inability of 
the sse1nbd allele to complement under any condition, suggesting that thermal stress may impose 
distinct requirements for Sse1 functions that include NEF and substrate holdase activities. To further 
probe this question, and to ask whether the presence of the closely related Sse2 protein masked 
growth defects of sse1sbd under non-heat shock conditions, I transformed sse1∆sse2∆ cells with 
sse1sbd- or SSE1-expressing plasmids using a plasmid shuffle technique (151). I again observed 
indistinguishable growth between the two alleles at 30°C, while sse1sbd was unable to maintain 
viability at 37˚C (Figure 4-6.A and B). Consistent with the phenotypes seen under thermal stress, cells 
grown in the presence of formamide, which acts as a general protein denaturant, exhibited 
phenotypes consistent with heat stress (Figure 4-6.C). Cells expressing the sse1nbd, or sse1sbd were 
hypersensitive to formamide, and this phenotype was augmented with combined heat stress. These 
results suggest that despite being unnecessary for substrate refolding and disaggregation in vitro, or 
resistance to other forms of proteotoxic stress, the Sse1 SBD and its holdase activity are important for 
cell physiology and survival under prolonged thermal stress.  
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Figure 4-6. Sse1sbd supports growth at normal but not heat shock temperatures. A. Serial dilution 
plating of sse1Δ or sse1Δsse2Δ cells complemented with the indicated plasmid-expressed SSE1 alleles 
and cultured at the indicated temperatures. Wedges below images represent relative cell density. B. 
Complementation of sse1Δsse2Δ with plasmid expressed Sse1 alleles at 30 °C. C. Serial dilution plating 
of sse1Δ cells complemented with the indicated plasmid-expressed Sse1 alleles cultured on 
formamide. 
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I envisioned two possible explanations to account for the results obtained from the growth 
analyses with sse1sbd. One is that Sse1 substrate binding is important only during heat stress due to 
physiological insults that occur exclusively under those conditions. The second possibility is that the 
Sse1 SBD is functioning at all times to maintain proteostasis. During normal growth conditions it 
minimally contributes to the chaperones network, but it is takes on a more impactful role during heat 
stress and is required to endure the increased burden on protein quality control systems. To 
determine if a non-functional Sse1 SBD has any impact on the proteome while cells are grown under 
optimal conditions, I assessed the activation of the heat shock response (HSR) as a proxy for 
disruption of proteostasis using an established HSE-lacZ reporter (131, 132). To prevent possible 
variability from plasmid expression in these and subsequent experiments, I chose to directly integrate 
the SSE1 mutants into the yeast chromosome at the endogenous locus. It is known that sse1∆ cells 
exhibit a two- to four-fold elevated HSR, consistent with chronic proteostatic imbalance (131). I 
confirmed that cells expressing the NEF-defective allele sse1nbd also demonstrated an activated HSR 
(Figure 4-7.A). Interestingly, cells expressing sse1sbd exhibited modest activation of the HSR (~1.8-fold) 
supporting the idea that the Sse1 SBD may play some role in proteome maintenance even during non-
stress conditions. As a complementary approach, I assessed Hsp90 expression since it is exclusively a 
target of Hsf1 (156, 157) (10). Using immunoblot analysis, I determined that the sse1∆, sse1nbd, sse1sbd 
cells exhibited a modest 1.5- to 3-fold increase in steady state Hsp90 levels in accordance with the 
HSR activation results (Figure 4-7.B). These data suggest that the holdase activity of Sse1 nominally 
contributes to proper functioning of the chaperone network under normal physiological conditions. 
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Figure 4-7. Loss of Sse1 holdase activity results in mild proteotoxicity. A. β-galactosidase activity 
assays from cells expressing the indicated SSE1 alleles integrated at the endogenous locus and 
expressing the HSF reporter pSSA3HSE-lacZ grown under optimal conditions and in the absence of 
stress (n=3). B. Protein lysates from cells grown to mid-log phase under optimal conditions and in the 
absence of stress were analyzed for Hsp90 protein levels by SDS-PAGE and immunoblot. Scanning 
densitometry quantitation of Hsp90 levels from blots and normalized to a PGK immunoblot as a load 
control (n=3). Error bars represent ± standard deviation (p< 0.05). 
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In addition to general contributions to proteostasis, Sse1 supports signal transduction and 
functions of Hsp90 (114). For example, sse1∆ cells are especially sensitive to inhibitors that target 
Hsp90-facilitated receptor activation such as geldanamycin and macbecin (131). To assess if this 
biological role required Sse1 to functionally interact with unfolded substrates, I used the maturation 
and activation of the mammalian glucocorticoid receptor (GR) in yeast cells as a benchmark of Hsp90 
activity. β-galactosidase activity was measured in cells co-expressing a glucocorticoid response 
element (GRE)-lacZ reporter and the different SSE1 alleles after activation of the GR via the synthetic 
hormone deoxycorticosterone (DOC) (Figure 4-8). Wild-type cells exhibited a robust response to DOC 
treatment indicative of GR activation. Likewise, cells expressing sse1sbd were also able to activate the 
GR, whereas activation was abolished in sse1∆ and sse1nbd cells indicating that the Sse1 substrate 
binding function is not required to contribute to this Hsp90-dependent activity. This is evidence that 
the NEF function of Sse1 is primarily involved in Hsp90-mediated receptor activation. 
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Figure 4-8. SBD function is not required for Hsp90-dependent glucocorticoid activation via Sse1. 
Cells were grown under optimal conditions and activation of the rat glucocorticoid receptor was 
measured via a LacZ reporter in the absence and presence of 10 µM deoxycorticosterone (DOC). 
Luminescence was measured and the relative light units (RLU) detected were graphed as a mean 
(n=4) with error bars representing ± standard deviation. *=p<0.05 and ns indicates no statistical 
difference. 
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Another established cellular role for Sse1 is its participation in the triage decision for Hsp70-
mediated protein folding versus degradation, wherein Sse1 is required for targeting terminally 
misfolded proteins to the proteasome for degradation. Specifically, Sse1 stimulates ubiquitination and 
degradation of the model misfolded protein CPYǂ-GFP, an engineered variant of the vacuolar protease 
carboxypeptidase Y that lacks the ER signal sequence and is permanently misfolded (132, 133). I 
utilized CPYǂ-GFP to assess if Sse1 substrate binding was important for targeting terminally misfolded 
proteins for degradation. After treating cells with cycloheximide, I tracked the clearance of CPYǂ-GFP 
in cells expressing SSE1, sse1ndb, or sse1sbd by immunoblot. In the presence of a fully functional Sse1 
protein, CPYǂ-GFP levels decrease in cells after cycloheximide treatment as the misfolded protein is 
degraded (Figure 4-9). I found that sse1nbd-expressing cells matched sse1∆ cells in their inability to 
clear the terminally misfolded protein after two hours of cycloheximide chase. In contrast, sse1sbd-
expressing cells fully cleared CPYǂ-GFP indicating that the Sse1 SBD function is not required for 
targeting terminally misfolded proteins for degradation. In addition to immunoblot analysis, I 
assessed the amount of CPYǂ-GFP aggregates forming in cells expressing the different Sse1 alleles and 
tracked their clearance over time using fluorescence microscopy. CPYǂ-GFP aggregate clearance 
correlated precisely with protein clearance (Figure 4-10.A and B). To test if Sse2 could be masking a 
substrate binding role for Sse1 in protein degradation, I used SSE1sse2∆ and sse1sbdsse2∆ strains 
(constructed by Unekwu Yakubu) and tracked the ability of these cells to clear the CPYǂ-GFP 
aggregates. Cells expressing the substrate binding deficient mutant cleared the aggregates at the 
same rate as SSE1sse2∆ cells (Figure 4-10.C and D). Although all the microscopy images were taken 
with equal exposures, the images of cells at 90 minutes have very bright backgrounds due to the 
overall decrease in cellular GFP signal. Together, these data strongly support the contention that Sse1 
substrate binding is not required to support Hsp90 signaling activities or to promote the degradation 
of terminally misfolded cytosolic proteins. 
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Figure 4-9. Sse1 SBD function is not required for clearance of the misfolded CPYǂ-GFP reporter. A. 
Immunoblot analysis of CPYǂ-GFP after a 2 hour cycloheximide treatment. Degradation of the CPYǂ-
GFP was analyzed using anti-GFP antibody and PGK was used a load control. B. Scanning densitometry 
quantitation was performed on anti-GFP blots and normalized to the PGK signal with in each sample. 
The remaining normalized level of GFP signal was plotted after the 2 hour cycloheximide treatment 
(n=3). 
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Figure 4-10. Sse1 SBD function is not required for clearance of the CPYǂ-GFP aggregates. A. 
Representative micrographs of the various SSE1 strains at 0 and 90 min after cycloheximide treatment 
to track CPYǂ-GFP aggregate clearance in the cell population. B. Quantitation of the experiments 
shown in (A), percentage calculated as aggregate containing cells relative to time zero. Three 
independent experiments were conducted and at least 95 cells were counted for each strain under 
each time point. Error bars represent standard deviation and **=p<.01. C. Representative 
micrographs of SSE1sse2∆ or sse1sbdsse2∆ strains tracking CPY
ǂ-GFP aggregate clearance at the 
indicated time points. D. Quantitation of the experiments shown in (D), percentage calculated as 
aggregate containing cells relative to time zero. Three independent experiments were conducted and 
at least 136 cells were counted for each strain under each time point. Error bars represent standard 
deviation, and ns indicates no statistical difference. All experiments were performed using cells 
expressing the indicated SSE1 alleles integrated at the endogenous locus. 
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Discussion 
 
Among the three classes of cytosolic NEFs, Hsp110/Sse is the sole family demonstrated to 
possess holdase activity for unfolded proteins, yet no in vivo role has been exclusively attributed to 
this domain. To address this quandary, I generated a novel Sse1 allele that disrupts the ability of the 
chaperone to prevent aggregation, presumably via substrate binding and sequestration, while 
maintaining interaction with Hsp70 and NEF activity. Data from our laboratory and others strongly 
suggest that the yeast cytosolic Hsp110s, Sse1 and Sse2, play critical cellular roles in maintaining 
protein homeostasis during physiological and stress conditions (114, 131, 132). This interpretation is 
bolstered by the fact that sse1∆sse2∆ cells are unviable and while overexpression of the other yeast 
NEFs can only partially complement growth phenotypes at 30˚C, the complete absence of Hsp110 
proteins can only be fully remedied by expression of either SSE1 or SSE2 (114). In all cases studied to 
date, elimination of Hsp110/Sse NEF activity phenocopies the gene deletion, suggesting that indeed, 
the NEF function is a primary, if not dominant, role for this class of chaperone. Known Sse1 roles that 
might additionally be impacted by loss of Hsp110/Sse holdase activity were tested such as refolding 
and disaggregation in vitro, responses to different proteotoxic stresses, signaling through Hsp90, and 
targeting of terminally misfolded cytosolic proteins for degradation. Strikingly, there was no 
demonstrable role for Sse1 SBD function in the reconstituted luciferase refolding or disaggregation 
reactions, leading us to conclude that the holdase activity is dispensable for these activities. Likewise, 
Hsp90-dependent signaling and protein degradation were fully supported by the Sse1sbd mutant. This 
is in apparent contrast to a recent study by the Hendershot group that identified two secretory 
pathway proteins, immunoglobulin γ1 heavy chain and NS-1 κ light chain, that are preferentially 
bound by the ER homolog of Hsp110, Grp170, and when this interaction is eliminated processing of 
these substrates is disrupted (158). Although these findings suggest a biological role for Grp170 
substrate binding, these same regions within the substrates are both aggregation-promoting and 
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recognized by the ER Hsp40 co-chaperones ERdj4 and ERdj5, precluding a clear interpretation. 
Additionally, models have been proposed wherein Hsp110 chaperones are competent to promote the 
folding of unfolded substrates when assisted by Hsp40 co-chaperones in an ATP-dependent folding 
cycle, an activity that would presumably rely on the SBD (111). However, the ability of catalytically 
inactive SSE1 mutant alleles to fully support known Sse1-dependent activities challenges the 
biological relevance of the observation by Matoo et al. in which Hsp110 was able to fold denatured 
substrates in the absence of Hsp70 (39, 128). 
It is possible that the Hsp110/Sse SBD plays a (minor and perhaps redundant) role in protein 
folding events that is magnified under certain stress conditions. For example, Sse1sbd was unable to 
serve as the sole Hsp110 allele under extended growth at 37˚C or in the presence of formamide, the 
latter a phenotype that I and others have demonstrated to be functionally analogous to thermal 
stress (159, 160). It cannot be excluded, however, that these phenotypes are ultimately more tightly 
linked with cell wall integrity than protein homeostasis, an idea reinforced by the clear suppression of 
sse1 mutant phenotypes with 1M sorbitol, an osmotic stabilizing agent (161).  
It may be relevant to consider that the Sse1sbd mutant is not completely defective in substrate 
binding, retaining between 20-50% of its aggregation prevention potential in a substrate-specific 
manner. It is possible that a complete abrogation of substrate interaction is necessary to reveal more 
dramatic phenotypes in the different Sse1 functions tested. However, I attempted to generate a more 
severe holdase-defective mutant through additional targeted amino acid substitutions based on the 
work of Liu and colleagues, without success (109). Importantly, I observed nearly identical outcomes 
in multiple in vitro and in vivo assays that are highly dependent on Sse1 and sensitive to perturbations 
in its status. Tellingly, the recently described role for Hsp110/Sse as a critical component of the 
eukaryotic disaggregase machine provided a prime opportunity to answer the open question of 
whether substrate holding by this family of proteins contributed to the remarkable ability of the 
Hsp110•Hsp70•Hsp40 complex to extract and refold aggregated proteins. Our findings support the 
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growing contention that Hsp110 NEF activity, not holdase activity, is the key accelerator of 
disaggregation in this context (54). However, as the Sse1sbd mutant is not completely without 
substrate binding capacity, I cannot yet formally exclude a role for substrate binding by Hsp110 
chaperones in disaggregation. The passive holdase activity of Hsp110/Sse has previously been shown 
to promote the refolding of luciferase by yeast cytosol, likely by stabilizing the unfolded polypeptide 
and preventing its aggregation. This activity may also be compared to subtle interactions under 
certain conditions with the Sup35 prion in yeast that appear to be independent of Sse1 NEF function 
(162, 163). In both these latter scenarios the Sse1 holdase function is likely operating independently 
of Hsp70.  
It may be of interest to further probe potential contributions of Hsp110/Sse1 holdase activity 
in aggregate prevention for specific aggregation-prone substrates. For example, Hsp105 in human 
cells is known to modulate cystic fibrosis transmembrane conductance regulator (CFTR) folding and 
processing (164).  Hsp110 suppresses the aggregation and associated toxicity of the mutant proteins 
that lead to amyotrophic lateral sclerosis and Alzheimer’s disease respectively, when expressed in C. 
elegans and mice  (123, 127). Hsp110 has also been found to be an important modulator of neuronal 
degeneration caused by the expression of toxic polyglutamine proteins that model Huntington’s 
disease in the fly (125, 126). Strikingly, Hsp110 can also ameliorate toxicity caused by the G85R 
variant of SOD1, a contributor to amyotrophic lateral sclerosis (ALS), significantly extending survival of 
SOD1G85R-YFP transgenic mice when overexpressed in motor neurons (165, 166). The specific 
mechanisms by which Hsp110 prevents aggregation and disease progression in these model systems 
are unknown. Given the increasing significance of Hsp110 chaperones in modulation of proteotoxic 
aggregation, it will be important to more precisely define the features that contribute to such 
activities as a precursor to therapeutically manipulating the chaperone network to combat 
progression of protein-misfolding disorders.  
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Chapter 5: A carboxyl-terminus regulated fluorescence affinity tag affects Sse1 functions 
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Introduction 
 
In parallel to the substrate binding function of SSE1 study discussed in chapter 4, I attempted 
to find additional mutants of Sse1 that were substrate-binding defective. This was of particular 
importance as the Sse1sbd mutant was only partially defective in substrate interactions (retained 20-
50% of substrate binding).  In particular, I hoped to identify mutants that completely abolished 
substrate interactions. In collaboration with Julie Heffler, an undergraduate student in the Morano 
laboratory, we attempted to use manganese and Taq polymerase-induced mutagenesis to isolate SBD 
mutants (130). The error-prone PCR mutagenesis screen was conducted by modulating Taq activity 
through MgCl2 levels and nucleotide concentrations thus inducing transcription errors during PCR 
amplification of the Sse1 SBD β-domain. The mutant β-domain DNA fragments amplified were 
transformed into yeast cells along with a linearized vector and the DNA for the NBD and α-domain of 
Sse1. Transformants were screened for wild-type growth at 30 ᵒC and a slow growth phenotype at 37 
ᵒC. Heffler identified ten SSE1 mutants that demonstrated the desired growth phenotypes and the 
candidates were analyzed for expression and protein stability at the two temperatures. 
Unfortunately, none of the candidates were stable at the elevated temperature indicating that the 
growth defect observed at 37 ᵒC was due to the absence of the Sse1 protein under that condition. 
Additionally, we characterized multiple SBD site-directed mutants that were based on Hsp70 and 
Hsp110 literature (103, 109, 167, 168). I built SSE1 alleles with the following mutations: SSE1-
SBD4V467T, SSE1-SBD5S440L, SSE1-SBD6P426L, and SSE1-SBD9Y404I,W406LL433A,N434P,F439L,M441A. The mutagenesis 
screen and the targeted mutants did not yield in any Sse1 proteins that displayed the phenotypes of a 
non-functional SBD while retaining stability and expression in vivo as well as Hsp70 interaction.  
Because these methods were unsuccessful in producing viable mutants, I utilized a previously 
developed strategy to modify Sse1 via a tunable, destabilized domain which acts a dominant degron 
in the absence of a small molecule ligand. A publication from the Goldberg laboratory used a 
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regulated fluorescent affinity (RFA) tag to control degradation of essential proteins in the parasite 
Plasmodium falciparum (169).  The RFA tag provides an avenue to knock down protein levels due to 
the inherent instability of the dihydrofolate reducatse (DHFR) degradation domain (DDD) it contains.  
The synthetic folate analog trimethoprim (TMP) binds the same site that folate binds within DHFR, so 
the compound can be used in vivo to stabilize the DDD and prevent its degradation (170, 171). 
Therefore, the RFA tag is unstable and degradation prone in the absence of a bound ligand but can be 
stabilized when a ligand such as TMP is available. The researchers observed that the RFA was not 
degraded when fused to PfHsp110 even in the absence of TMP, indicating some level of protection by 
the molecular chaperone in P. falciparum. Their data suggested that the RFA tag fused to the C-
terminus of PfHsp110 was bound by the chaperone’s SBD to protect the unstable domain and prevent 
its degradation (169).   
Based on these findings, the RFA tag was used as a tool to study the substrate binding 
capabilities of Sse1. I proposed that the misfolded DDD in the absence of TMP would be recognized by 
the Sse1 acting as a physical occlusion in the SBD of the chaperone. The RFA tag could be manipulated 
through the absence or presence of TMP as an occluded or liberated Sse1 SBD, respectively. In this 
study, the SSE1-RFA strain was often characterized along with sse1sbd as I expected that the two 
proteins were inhibited in the ability to interact with substrate and would therefore show similar 
phenotypes. While the sensitivity to proteomic stressors was similar, the cells expressing SSE1-RFA 
were distinctively defective in degradation and aggregate clearance of a misfolded cytosolic protein. 
Furthermore, the observed degradation defects in the SSE1-RFA strain were not rescued in the 
presence of TMP. The data presented here suggest that the defects of the SSE1-RFA strain 
demonstrates might be due to the presence of a tag on the C-terminus of Sse1 and not because the 
tag contains a DDD within. To address this, I compared the SSE1-RFA strain to a strain which 
expressed an Sse1 protein with a C-terminus GFP fusion (SSE1-GFP). Cells expressing SSE1-GFP also 
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demonstrated reduced thermal tolerance at 37 ᵒC. These data suggest that a blocked C-terminus 
interferes with specific Sse1 activities, possibly its roles in degradation.  
 
Results 
 
 Given the work recently published by Muralidharan et. al., Sse1-RFA was used to characterize 
the substrate binding function of Sse1 (130, 169). The RFA tag was hypothesized to interfere with the 
ability of the Sse1 SBD to recognize or bind an unfolded polypeptide (Figure 5-1). This tag could serve 
as a regulated Sse1 protein which could have an occluded SBD in the absence of trimethoprim (TMP) 
and a liberated SBD in the presence of TMP which stabilizes the DDD within the tag. The SSE1-RFA 
genetic construct was built by Julie Heffler, and she characterized SSE1-RFA cells for growth, assessed 
the stability of Sse1-RFA in the presence and absence of TMP, and assessed the ability of the protein 
to interact with Ssa and Ssb in vivo (130).  
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Figure 5-1. Model of Sse1 fused to a carboxyl-terminus regulated fluorescence affinity (RFA) tag. 
The RFA tag contains a GFP domain followed by a DHFR degradation domain (DDD) with an HA-tag on 
the C-terminus. The degradation domain is inherently unstable and misfolded but can be stabilized in 
the presence of the ligand, trimethoprim (TMP). When RFA is fused to Sse1, the unstable DDD is 
recognized by the SBD of the chaperone to prevent degradation. 
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To verify the functionality of SSE1-RFA, I wanted to assess complementation of the sse1∆ 
strain growth phenotypes (130). Plasmid-borne SSE1 alleles were expressed in sse1∆ cells and growth 
was compared under optimal conditions, during cold stress, and heat stress (Figure 5-2.A). SSE1-RFA 
cells show phenotypes very similar to those observed for the sse1sbd cells. Under optimal conditions 
(30 ᵒC) and cold stress (15 ᵒC), both alleles complement the sse1∆ slow growth phenotypes and grow 
significantly better than the non-functional sse1nbd cells. These data demonstrate that the SSE1-RFA 
allele is a functional copy of SSE1 under these conditions. When cells are grown under heat stress (37 
ᵒC) SSE1-RFA cannot complement the slow growth phenotype of the sse1∆ cells. The phenotypes 
observed for SSE1-RFA cells reproduce the phenotypes expected for a non-functional Sse1 substrate 
binding domain mutant such as the Sse1sbd (Figure 4-5). Previous work by Julie Heffler demonstrated 
that SSE1-RFA cells are rescued from heat sensitivity when grown under the presence of TMP (cite 
Julie’s thesis). I grew cells at 37 ᵒC with TMP, and obtained comparable results (Figure 5-2.A). The 
phenotypic rescuing by TMP suggested that the RFA tag was functioning as predicted (Figure5-1). 
Finally, similar to the phenotype of sse1sbd cells, the SSE1-RFA allele cannot complement the lethality 
of sse1∆ sse2∆ cells at 37 ᵒC (Figure 5-2.B). These data also indicate that the Sse1-RFA protein is 
functional under most conditions except under heat stress. In addition to heat stress, sse1∆ cells 
complemented with the different SSE1 alleles were also grown in the presence of formamide, a 
general protein denaturing agent (Figure 5-3). The phenotypes observed for SSE1-RFA cells were 
similar to those of the sse1sbd mutant. These data suggest that Sse1-RFA could be functioning in a 
similar fashion to the substrate binding domain mutant Sse1sbd.  
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Figure 5-2. Sse1-RFA phenocopies the sensitivity to heat stress of the Sse1 substrate binding 
mutant. A. Serial dilution plating of sse1Δ cells complemented with the indicated plasmid-expressed 
SSE1 alleles and cultured at the indicated temperatures and in the presence of TMP. Wedges below 
images represent relative cell density. B. Complementation of sse1Δsse2Δ with plasmid expressed 
SSE1 alleles. 
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 Figure 5-3. Similar to a substrate binding mutant, Sse1-RFA is sensitive to formamide. Serial dilution 
plating of sse1Δ cells complemented with the indicated plasmid-expressed Sse1 alleles cultured on 
formamide at the indicated temperatures. 
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I assessed if cells expressing the SSE1-RFA cells would behave like sse1sbd cells in a series of 
experiments that I performed characterizing the substrate binding mutant (Chapter 4). Evaluating 
these functions would require proper regulation of the SSE1 variants, so SSE1-RFA was integrated into 
the yeast genome via allelic exchange. To ensure that SSE1-RFA cells were growing like the parental 
strain (WT) as well as the SSE1 integrant, I calculated doubling times of the different SSE1 strains 
under optimal conditions as a measurement of growth rate. As expected, WT, SSE1, sse1sbd, and SSE1-
RFA strains had similar doubling times of approximately 126 minutes.   The sse1∆ and sse1nbd strains 
grew more slowly and had doubling times of 261 or 178 minutes respectively (Figure 5-4.A). It is 
established that sse1∆ cells exhibit a two- to four-fold elevated HSR, consistent with a proteostatic 
imbalance (131). First, I wanted to assess the state of heat shock response (HSR) regulation as a 
marker for general proteotoxicity. sse1∆ cells and those expressing the NEF-defective allele sse1nbd 
demonstrated an activated HSR (Figure 5-4.B). Interestingly, SSE1-RFA cells had a lower activation (not 
significant) of the HSR (~1.2 fold) compared to sse1sbd cells (~1.8-fold). Hsp90 is exclusively a target of 
Hsf1, the master transcription regulator of the heat HSR (10, 156, 157). In parallel with the HSR 
activation experiments, I measured Hsp90 protein levels (Figure 5-4.C). Corresponding with the HSR 
activation results, the immunoblot analysis determined that the sse1∆, sse1nbd, sse1sbd cells exhibited 
a modest 1.5- to 3-fold increase in steady state Hsp90 levels. SSE1-RFA cells displayed Hsp90 levels 
between those of WT and the sse1sbd cells, much like the results for the HSR activation experiment. 
These data suggest that Sse1 holdase activity contributes minimally to proper functioning of the 
chaperone network and proteostasis under normal physiological conditions and lack of this function 
results in a slight proteomic imbalance. SSE1-RFA cells were better able to maintain proteostasis than 
sse1sbd cells, and these somewhat dissimilar phenotypes suggest that the defects of the Sse1-RFA 
mutant are different from that of Sse1sbd. Interestingly, cells that express sse1nbd cells demonstrate a 
higher derepression of the HSR in both the HSR-LacZ experiments as well as the analysis of Hsp90 
levels, but the strain does not have a growth defect as severe as the sse1∆ cells. This suggests that the 
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presence of a NEF defective Sse1 protein in the cell functions as a dominant negative and has a 
proteotoxic effect. This observation was noted but was not further addressed experimentally.  
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Figure 5-4. Sse1-RFA cells grow like wild-type cells and demonstrate a negligible HSR activation. A. 
Doubling time in minutes for the WT (BY4741), sse1∆, and the various SSE1 genomic integrants (n=4). 
B. β-galactosidase activity assays from cells expressing the indicated SSE1 alleles integrated at the 
endogenous locus and expressing the HSF reporter pSSA3HSE-lacZ (n=3). Data was normalized to WT 
(parent strain). C. Protein lysates from cells grown to mid-log phase were analyzed for Hsp90 protein 
levels by SDS-PAGE and immunoblot. Scanning densitometry quantitation of Hsp90 levels from blots 
and normalized to a PGK immunoblot as a load control (n=3). Error bars represent ± standard 
deviation. *=p<0.05, **=p<0.01, ***=p<0.005, and ns indicates not statistically different. 
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As discussed in Chapter 4, Sse1 promotes signal transduction and functions of Hsp90 (114, 
131). I used the activation of the mammalian glucocorticoid receptor (GR) in yeast cells as a 
benchmark of Hsp90 activity, to evaluate if the Sse1-RFA mutant had deficiencies in this biological role 
of Sse1. β-galactosidase activity was measured in cells co-expressing a glucocorticoid response 
element (GRE)-lacZ reporter and the different SSE1 alleles after activation of the GR via treatment 
with the synthetic hormone deoxycorticosterone (DOC) (Figure 5-5). WT, SSE1, sse1sbd, and SSE1-RFA 
cells exhibited a robust response to DOC treatment indicative of GR activation, whereas activation 
was abolished in sse1∆ and sse1nbd cells implying that the NEF activity of Sse1 primarily drives 
maturation of the GR via Hsp90. 
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Figure 5-5. Sse1-RFA is capable of activating the Hsp90-dependent glucocorticoid receptor via Sse1.  
Cells were grown under optimal conditions and activation of the rat glucocorticoid receptor was 
measured via a LacZ reporter in the absence and presence of 10 µM deoxycorticosterone (DOC). 
Luminescence was measured and the relative light units (RLU) detected were graphed as a mean 
(n=4) with error bars representing ± standard deviation. *=p<0.05. 
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Lastly, SSE1-RFA cells were tested for ability to execute the Sse1 established role of targeting 
terminally misfolded proteins for degradation. I assessed this role in vivo by using CPYǂ-GFP which is 
an engineered, terminally misfolded protein from the vacuolar protease carboxypeptidase Y that lacks 
the ER signal sequence (131, 132). Cells were treated with cycloheximide to pause translation, and 
CPYǂ-GFP clearance was assessed via immunoblot (Figure 5-6.A). CPYǂ-GFP was stabilized in sse1∆ 
cells expressing the vector, sse1nbd, and SSE1-RFA, whereas cells expressing SSE1 or sse1sbd were able 
to degrade the model substrate. Additionally, I tracked clearance of CPYǂ-GFP aggregates in cells 
containing the variant SSE1 alleles as genomic integrations following cycloheximide treatment (Figure 
5-6.B and C).  Microscopic visualization demonstrated that SSE1-RFA cells have phenotypes 
resembling those of sse1∆ and sse1nbd cells as they were unable to clear the CPY
ǂ-GFP aggregates. 
Additionally, the micrograph image of SSE1-RFA cells that are not expressing CPYǂ-GFP demonstrates 
that Sse1-RFA is a soluble protein and remains appropriately distributed throughout the cytosol 
(Figure 5-6.B). Data from these experiments indicate that Sse1-RFA, in contrast to Sse1sbd, is not able 
to target this misfolded protein for degradation. The inability of Sse1-RFA to clear CPYǂ-GFP from cells 
might be due to an inhibition of the substrate binding function through the occlusion of the substrate 
binding domain. Given that the sse1sbd cells were not defective degrading CPY
ǂ-GFP or in clearing its 
aggregates, there was also the possibility that the phenotypes observed for SSE1-RFA were not due to 
defective substrate binding function but something else being affected by the  presence of the RFA 
tag.  
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Figure 5-6. Sse1-RFA is non-functional in clearing the misfolded CPYǂ-GFP substrate. A. Degradation 
of CPYǂ-GFP was analyzed in sse1∆ cells expressing the plasmid-borne SSE1 variants. Immunoblot 
analysis of CPYǂ-GFP degradation was performed at 0, 1, or 2 hours after cycloheximide treatment 
was using anti-GFP antibody and PGK was used a load control. B. Representative micrographs of the 
various SSE1 strains at 0 and 90 min after cycloheximide treatment to track CPYǂ-GFP aggregate 
clearance in the cell population. C. Quantitation of the experiments shown in (B), percentage 
calculated as aggregate containing cells relative to time zero. Three independent experiments were 
conducted and at least 95 cells were counted for each strain under each time point. Error bars 
represent standard deviation and **=p<.01.  
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To test these possibilities, I repeated the experiments using the CPYǂ-GFP reporter in the 
presence or absence of TMP. Given that TMP can rescue the growth defect of the SSE1-RFA strain 
under heat conditions (Figure 5-2) (130), I expected that TMP would improve CPYǂ-GFP degradation. 
Surprisingly, TMP did not have an effect on Sse1-RFA function. Immunoblot analysis to assess the 
degradation of the protein showed that CPYǂ-GFP was stabilized in SSE1-RFA cells whether or not TMP 
was present (Figure 5-7.A).  Additionally, tracking the clearance of CPYǂ-GFP via microscopy also 
demonstrated a TMP independent accumulation of aggregates (Figure 5-7.B). 
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Figure 5-7. TMP does not rescue the clearance defect of SSE1-RFA cells. A. Degradation of CPYǂ-GFP 
was analyzed in sse1∆ cells expressing the plasmid-borne SSE1 variants in the presence or absence of 
TMP. Analysis was performed at 0, 1, or 2 hours after cycloheximide treatment was using anti-GFP 
antibody and anti-PGK as a load control. B. Cells were grown in the absence (solid lines) or presence 
(dotted lines) of 500 µM TMP. At least 90 cells per sample were visualized and cells containing foci of 
total were counted at 0, 1, or 2 hours after cycloheximide treatment.  Percentage calculated as 
aggregate containing cells relative to time zero.   
81 
 
Given the data obtained from the HSR activation and the CPYǂ-GFP substrate clearance 
experiments, it was important to consider that Sse1-RFA was not behaving like the substrate binding 
domain mutant, Sse1sbd. Furthermore, the inability of TMP to rescue the CPY
ǂ-GFP clearance defect 
suggested that something other than SBD occlusion might be occurring with the Sse1-RFA protein. 
Therefore, I hypothesized that Sse1-RFA was showing phenotypic defects due to the placement of the 
RFA tag which could be interfering with other Sse1 activities. Experiments similar to those previously 
conducted using the PfHsp110 were used to characterize the Sse1-RFA (169). I used proteins with an 
N-terminus FLAG-tag expressed in sse1∆ yeast cells to measure the availability, or exposure, of the 
different domains of Sse1-RFA. The RFA tag is comprised of a GFP domain, the DDD, and an HA-tag at 
the C-terminus (Figure 5-1). If the DDD was bound by the substrate binding domain of Sse1, the GFP 
domain would be less available to bind antibodies in its native state during an immunoprecipitation 
(IP) based on the previous characterization of an Hsp110-RFA fusion (169). To ensure that the 
proteins, F-Sse1, F-Sse1-RFA, and F-RFA, were expressed and properly folded, I began by conducting 
an immunoprecipitation using FLAG antibody resin (Figure 5-8.A). As expected, the FLAG-tag 
effectively immunoprecipitated all of the proteins as it is located at the N-terminus and is likely not 
affected by  SBD function or the presence of a tag at the C-terminus. Concurrent with what was 
previously published, the FLAG-IP results reproduced data demonstrating that Sse1-RFA can interact 
with the yeast cytosolic Hsp70 proteins suggesting that the NEF activity of the protein is intact (130). 
A second IP was performed using Sepharose beads conjugated with anti-GFP monoclonal antibody 
(Figure 5-8.B). If the RFA tag is bound by the SBD of Sse1, the GFP domain of Sse1-RFA would be less 
available compared to that of the RFA tag alone. The GFP domain appeared to be available in the 
Sse1-RFA fusion as well as the RFA alone. While these data do not guarantee that the DDD is not 
bound by the Sse1 SBD, it does provide evidence that the GFP domain in the Sse1-RFA fusion is 
unobstructed in the native state. 
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Figure 5-8. The Sse1-RFA domains are accessible in vivo. A.  Immunoprecipitation experiments using 
FLAG-tagged proteins were performed using anti-FLAG conjugated resin. Samples were analyzed via 
Coommassie stain on an SDS-PAGE. B. anti-GFP IP was performed using Sepharose beads conjugated 
with anti-GFP monoclonal antibody. Samples were analyzed via SDS-PAGE and Coommassie stain.  
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The results of the IP experiments provided evidence that the phenotypes observed for SSE1-
RFA cells were likely due to the presence of a tag on the C-terminus of the protein and not to the tag 
being recognized as unstable and bound by the Sse1 SBD. I used GFP as a large alternative tag fused to 
the C-terminus of Sse1 to test this conclusion (molecular weight: RFA 46 kDa, GFP: 27 kDa). SSE1-GFP 
cells grow like WT cells under optimal conditions but have a growth defect under heat stress (Figure 
5-9. A). Sse1 protein levels of the different strains where assessed by immunoblot and growth was 
compared for the different SSE1 variants (Figure 5-9.B). The observed thermal sensitivity of the SSE1-
GFP strain phenocopies that of the SSE1-RFA strain. This indicates that the presence of a fused tag on 
the C-terminus of Sse1 renders it unable to function optimally during heat stress. The sensitivity to 
elevated temperatures exhibited by the Sse1-RFA and Sse1-GFP mutants indicate that heat stress 
tolerance might require Sse1 interactions that are conferred by the extreme C-terminus of the 
chaperone. 
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Figure 5-9. A GFP tag on the C-terminus of SSE1 results in growth phenotypes similar to the SSE1-
RFA strain. A. Serial dilution plating of cells expressing the various SSE1 alleles integrated in the yeast 
genome, including SSE1-RFA and SSE1-GFP, and cultured at the indicated temperatures. Wedges 
below images represent relative cell density. B. SSE1 strains were serially diluted and cultured under 
different temperature conditions.  Protein lysates from cells were analyzed by immunoblots 
performed in parallel to the growth on solid media to determine protein expression levels. The 
numbers below the anti-Sse1 immunoblot indicate the Sse1 protein level relative to the WT for each 
temperature. PGK was used a load control and to normalize quantification.   
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Discussion 
 
 Initially, Sse1-RFA was proposed as an alternative method to study the substrate binding 
domain functions of SSE1. In the initial phases of the study, SSE1-RFA cells phenocopied the sse1sbd 
strain (Figure 5-2). It was stable in yeast and maintained interactions with the cytosolic Hsp70s at 30ᵒ 
C and 37ᵒ C  (130) (Figure 5-8.A and B) It was particularly striking that SSE1-RFA cells demonstrated a 
comparable sensitivity to heat, complete tolerance for cold stress, and complementation of the non-
viable sse1∆sse2∆. Furthermore, the heat sensitivity was rescued by the presence of TMP as was 
previously demonstrated (130). In addition to the growth assessments under optimal and stress 
conditions, the SSE1-RFA strain displayed phenotypes that were slightly more defective that the SSE1 
strain but less impacted than the sse1sbd strain in the assessments for the HSR regulation and the 
activation of the glucocorticoid receptor (Figure 5-4 and 5-5). Taking these data together with the 
work that was published using the PfHsp110-RFA, I posited that Sse1-RFA was a protein that was 
defective in binding substrate due to the occlusion of the chaperone SBD by the DDD within the RFA 
tag. I tested the ability of Sse1-RFA to function as a holdase in vitro using the aggregation assay 
discussed in chapter 3. Although the data were preliminary (protein purity was low and only one 
protein preparation was tested), they suggest that Sse1-RFA can bind unfolded citrate synthase 
similarly to Sse1 (data not shown).  
 Surprisingly, during testing each Sse1 variant in its ability to degrade CPYǂ-GFP, the SSE1-RFA 
strain provided phenotypes that were very different from those observed in the sse1sbd strain. These 
results could be for two different reasons. One reason could be that the Sse1-RFA had a higher degree 
of inhibition in binding substrate than the Sse1sbd that has up to a 50% reduction in its ability to 
interact with unfolded substrates compared to Sse1 (Figures 4-2 and 4-3). If the Sse1-RFA SBD is 
occluded by the RFA tag, it could be a complete inactivation of substrate binding by the pool of Sse1-
RFA in the cell given each chaperone is fused to a tag. The high degree of substrate binding inhibition 
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in Sse1-RFA could result in the complete loss in ability to degrade CPYǂ-GFP or clear aggregates (Figure 
5-6). The data presented in Figure 5-7 suggest that this rationale is incorrect because the presence of 
TMP, which stabilizes the DDD within the RFA tag, does not rescue the CPYǂ-GFP degradation or 
aggregate clearance phenotype in SSE1-RFA cells. Moreover, the immunoprecipitation experiments 
did not indicate that the RFA is bound or occluded by the chaperone (Figure 5-8). There is still more 
characterizing that needs to be completed in order to determine the availability of each domain in the 
native Sse1-RFA.  
 If Sse1-RFA does not have a higher degree of inhibition in binding substrate than the Sse1sbd, 
the other possibility is that the presence of the tag on C-terminus is preventing certain Sse1 functions. 
This second possibility is supported by the data presented (Figure 5-7 and Figure 5-9).  Cells 
expressing Sse1 fused with a C-terminal GFP (strain SSE1-GFP) also demonstrate sensitivity to heat. To 
make a definitive conclusion regarding the effect a C-terminus tag has on Sse1 function, Sse1-RFA and 
Sse1-GFP need to further characterized and compared. Moreover, Sse1 is known to work 
cooperatively with the ubiquitin proteasome system when triaging terminally misfolded proteins for 
degradation (132, 133, 153). It is possible that the degradation defects seen for the SSE1-RFA strain 
might be due to the presence of the C-terminal tag which somehow inhibits those functions. 
Ultimately, characterization of Sse1-RFA and other C-terminus obstructions would further our 
understanding of Sse1 involvement in roles like targeting misfolded proteins for degradation.  
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Chapter 6: Characterization of the Drosophila melanogaster Hsp110 (Hsc70cb) 
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Introduction 
 
In the cellular environment, proteins frequently encounter stress conditions that can cause 
misfolding and aggregation. Additionally, genetic mutations can occur within cells that produce 
irregular proteins which also form aggregates. Cellular protein inclusions caused by misfolded 
proteins lead to cytotoxicity and disease (5). To reduce the potential effects of protein damage, a 
network of molecular chaperones is deployed to protect the proteome by helping proteins fold or 
clearing them from the cell. In animals, the inability of chaperones to counteract excessive protein 
misfolding can lead to amyloid fibrillar aggregates that deposit around brain neurons contributing to 
the development or progression of neurodegeneration: Alzheimer’s disease, Huntington’s disease and 
Parkinson’s disease are all fundamentally diseases of protein misfolding (116, 117).  A complete 
understanding of the mechanisms of protein quality control is required to allow treatment of these 
devastating pathological states. 
Drosophila melanogaster is an excellent multicellular organism in which to study the 
molecular basis of protein misfolding disorders. While flies cannot precisely reproduce the symptoms 
associated with human neurodegenerative disorders, consequences of expressing the human mutant 
protein that is characteristic of the disease can be visualized as phenotypes in a tissue specific 
manner, usually the fly eye (172). Using Drosophila in this type of model can help in two ways. The 
model can be used to gain an understanding of the molecular mechanisms that drive the pathology, 
and also to find strategies to repress phenotypes of the mutant, disease-prone protein.  Hsc70cb, the 
fly Hsp110, was uncovered through an RNAi screen to be one of the most potent suppressors of 
polyglutamine Htt aggregation in Drosophila cells (125). Using established fly models of Huntington’s 
disease with controlled Hsp110 levels, confirmed that this chaperone could affect the formation of 
aggregates as well as the progression of neuronal degradation (125, 126). Furthermore, Hsp110 
associates with polyglutamine proteins in vivo, and in vitro studies indicate that this interaction is 
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conferred through the SDB β domain of the chaperone(124). These studies provide motivation for 
understanding how Hsp110 chaperones might interact with disease-prone proteins that contain 
polyglutamine tract expansions.  
In this study, I sought to characterize the D. melanogaster Hsp110 protein, Hsc70cb, and 
develop mutants that were defective in binding substrate. Hsc70cb demonstrated holdase function in 
the established in vitro aggregation assay (Chapter 3) which can be used to characterize substrate 
binding mutants. Characterization of the wild-type Hsc70cb and a mutant collection could be utilized 
to study the role that Hsp110 proteins play in modulating the disease progression in animal models of 
neurodegenerative disorders. 
 
Results  
 
Hsp110 chaperones are a highly conserved family of proteins that exists in eukaryotes (40, 
152). There are two Hsp110 homologs in yeast, one in flies, and three in humans (Figure 6) (65, 173, 
174). Since flies only possess one gene that produces an Hsp110 protein, Hsc70cb, it makes this a 
good animal model in which to study Hsp110 function as effects from homologs can be minimized. 
The knowledge gained from studying the Sse1 substrate binding function can be utilized to 
characterize the Hsc70cb given their high degree of conservation. The two proteins share 57% 
similarity and highly comparable substrate binding domains.  
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Figure 6-1. Characterizing the substrate binding domain in yeast, fly and human biology. A. Hsp110 
homologs across various species B. Hsc70cb SBD structure (gray) was modeled based on the Sse1 
crystal structure (blue) using Protein Homology/Analogy Recognition Engine V 2.0 (PHYRE 2) with a 
confidence of 99.2% (59, 175).  
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To evaluate if the proteins shared functional homology with each other, Hsc70cb was 
expressed from a plasmid in sse1∆ cells and growth was assessed under optimal conditions and under 
heat stress. The Hsc70cb expressing strain shows the same slow growth phenotypes of the sse1∆ cells 
at either temperature indicating that the fly protein cannot functionally complement deletion of the 
yeast HSp110 (Figure 6-2.A). These results could be due to poor expression or stability of the Hsc70cb 
protein or because the D. melanogaster protein was not contributing to the yeast chaperone network. 
To answer this question, FLAG-tagged Sse1 or Hsc70cb proteins were expressed in sse1∆ cells and a 
FLAG immunoprecipitation was used to assess the ability of each Hsp110 protein to interact with the 
yeast cytosolic Hsp70 (Ssa/Ssb) proteins (Figure 6-2.B). Whereas Hsp70 co-immunoprecipitated with 
66% of Sse1, Hsp70 only co-immunoprecipitated with 18% of Hsc70cb (Figure 6-2.C). The slow growth 
phenotype observed for the sse1∆ cells complemented with Hsc70cb was likely due to the inability of 
the fly protein to interact with the yeast Hsp70 proteins. These results indicate that the Hsc70cb 
cannot functionally complement the deletion of the yeast Hsp110 proteins.  
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Figure 6-2. Hsp70cb does not complement an sse1∆ or interact with the yeast Hsp70s. A. Serial 
dilution plating of sse1Δ cells complemented with the SSE1 or Hsc70cb alleles expressed from a 
p413TEF vector and cultured at the indicated temperatures. Wedges below images represent relative 
cell density. B. Co-immunoprecipitation experiments using FLAG-tagged Hsp110 proteins were 
performed to assess interactions with the yeast Ssa and Ssb proteins. Samples were analyzed via 
Coommassie stain on an SDS-PAGE. C. Quantitative analysis of band densities in (B). Error bars 
indicate ± standard deviation and *=p<0.05. 
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 Hsc70cb was tested for its ability to function as a nucleotide exchange factor using 
recombinant protein purified from E. coli (Figure 6-3.A) (Figure 6-4). Human Hsc70 (HSPA8) had a high 
level of nucleotide exchange in the presence of Hsc70cb. In fact the fly Hsp110 protein was a more 
robust NEF when compared with Sse1. After ensuring that the purified Hsc70cb was NEF-functional, 
the holdase activity of Hsc70cb could be assessed. Due to their high degree of conservation, I 
expected that Hsc70cb would possess substrate binding function similar to other Hsp110 chaperones, 
including those of yeast and mammals (30, 106, 107, 111). I measured its ability to prevent the 
aggregation of chemically denatured firefly luciferase (FFL) using an established assay system (134). 
Hsc70cb prevented the aggregation of FFL to a level that was comparable to SSE1 establishing that 
Hsc70cb maintains the holdase function that is characteristic of Hsp110 chaperones.  
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Figure 6-3. Substrate holding function is conserved in Hsp70cb. A. Nucleotide exchange activity 
assays using HSPA8 (Hsp70) pre-bound to α-32P-ATP in the absence of NEF, or in the presence of 
Hsc70cb or Sse1 for 15 min. B. Substrate aggregation experiments conducted using chemically 
denatured CS (200 nM) diluted into refolding buffer without chaperone, with Hsc70cb (400 nM), or 
with Sse1 (400 nM). 
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Figure 6-4. Recombinant protein purification of Hexa-histidine tagged Hsc70cb. A. SDS-PAGE of 3 µg 
of recombinant His6-Hsc70cb purified from E. coli visualized by Coommassie stain. 
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Discussion 
Initially, I proposed screening Hsc70cb SBD mutants by expressing the fly proteins in sse1∆ 
yeast cells. Given that the substrate binding defective mutants cannot complement the heat 
sensitivity phenotype in this strain, this could be a quick and useful read-out to screen mutants. 
Hsc70cb cannot complement an Sse1 deletion and  cannot interact with the yeast cytosolic Ssa/Ssb; 
therefore it is not possible to conduct this screen or study how Hsc70cb substrate interaction might 
contribute to a chaperone network in vivo using yeast cells their chaperone networks. The Hsc70cb 
chaperone will have to be characterized mechanistically in vitro and functionally characterized in the 
fruit fly. To study the substrate binding function of Hsc70cb, I propose several mutants that target the 
SBD of the protein (Figure 6-4). Hsc70cbsbd is a mutant that is analogous to the Sse1sbd characterized in 
Chapter 5.  Hsc70cbsbd9 has two additional residue substitutions at positions V401 and W403 that 
target the putative binding site located within SBD-β stand β1 and L1,2 (Figure 6-1.B) (109). While the 
Sse1-RFA mutant still needs to further characterized to determine its substrate binding capacity 
(Chapter 5), the fact that it demonstrated deficiencies in the clearance of misfolded protein make this 
a suitable candidate to test in the polyglutamine Htt fly model. Once the defect is mechanistically 
defined for the C-terminus tag, this information can be used to study Hsc70cb. The proposed mutants 
with internal deletions are based on the known Sse1 crystal structures as well as literature that has 
characterized Hsp110 substrate binding in vivo (107) (124) (60) (104) (109). The mutants proposed 
here can be tested for holdase function using the aggregation assay I established (Chapter 3 and 
Figure 6-3.B). Developing mutants of Hsc70cb which are defective in specific functions and comparing 
those mutants to wild-type or NEF defective proteins will help further our understanding of the role 
that Hsp110 is playing in modulating the progression of the Huntington model of disease.  
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Figure 6-4. Proposed mutants to characterize the substrate binding function of Hsc70cb while 
retaining the NEF function. These Hsc70cb mutants target the SBD-β domain of the protein with 
either targeted residue substitutions (depicted as a black x) or internal deletions (depicted as a dotted 
line).  
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Recently, the Hsp70, Hsp40, and Hsp110 chaperone machine has been established as a 
powerful metazoan disaggregase machine with the capacity to resolublilize proteins (54, 110, 111, 
155). Hsp110 proteins possess distinct molecular activities which include driving the nucleotide-
dependent Hsp70 as well as its independent substrate binding domain. These characteristics make it a 
worthy chaperone to study in regard to neurodegenerative disorders and their causative cytotoxic 
proteins. In a screen conducted by Dr. Sheng Zhang, he discovered that Hsp110 alleviates the 
degenerative effects of aggregate formation by mutant Htt in D. melanogaster (125). Despite being 
implicated in this and other amyloid disease models, Hsp110 has not been characterized for its 
physiological role or how it may be contributing to protein quality control. It remains unknown how 
the two distinct functions of Hsp110 contribute to neuronal protection.  The knowledge gained from 
this project can be applied to test whether the NEF or SBD function of Hsp110 is important in 
modifying the progression of polyglutamine Htt based degeneration in the fly.  
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Chapter 7: Discussion 
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Summary 
 
 In this thesis, I present an analysis of the functions conferred by the substrate binding domain 
of Hsp110 chaperones. In chapter 3, a novel technique is described which is used to characterize the 
molecular dynamics of large protein complexes such as protein aggregates. I illustrate how a 
microplate reader can be used to obtain signals comparable to right angle light scattering, which 
typically requires a fluorimeter with a stirrable, temperature-controlled cell holder. The method 
presented uses less protein and reagents, with the advantage of being able to test multiple conditions 
in parallel. This account is an alternative method that can detect formation of rhodanese and citrate 
synthase aggregates as well as the differential prevention of aggregate formation by the molecular 
chaperone Sse1 with the same sensitivity as traditional methods of light scattering. Chapter 4 builds 
on this technological development to characterize the substrate chaperoning capacity of Sse1, the 
yeast Hsp110, through biochemical analysis. Furthermore, the work presented defines, for the first 
time, the contribution of Sse1 substrate binding to the maintenance of cellular proteostasis. The work 
presented in chapter 5 characterized a fusion protein of Sse1 which contained a regulated 
fluorescence affinity tag. I anticipated that this protein fusion would render the substrate binding 
domain of Sse1 non-functional, however several lines of evidence presented in the chapter suggest 
that the SBD may remain competent while the carboxyl-terminal fusion interferes with a role for Sse1 
in targeting substrates for degradation. Further characterization will have to be completed to 
determine if the fusion protein is in fact inhibited for SBD function or an alternative Sse1 role or 
interaction. Finally, Chapter 6 established that the fruit fly Hsc70cb behaves like a canonical Hsp110 
with regard to interaction with Hsp70 and its ability to induce nucleotide exchange from the 
chaperone. Additionally the data presented demonstrated that Hsc70cb can function as a holdase to 
chaperone unfolded polypeptides. This creates a platform upon which Hsp110 functions can be 
probed in a model for polyglutamine-mediated neurodegeneration in flies.  
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Hsp110 as a nucleotide exchange factor and a substrate chaperone 
 
Among the eukaryotic NEFs, which include the mitochondrial GrpE, and the cytosolic HspBP1, 
and BAG families, the Hsp110 classes distinctively possess a substrate binding domain and therefore 
are unique in their ability to interact with unfolded polypeptides. The nucleotide exchange function of 
Hsp110 proteins has been extensively characterized (44, 45, 105, 152). The potent NEF activity of 
these proteins is widely accepted as the driving force behind many Hsp70-mediated functions. 
Previous work has characterized the substrate binding function of Hsp110 chaperones. Prior to this 
study, it was known that Sse1 as well as mammalian Hsp110 can bind unfolded polypeptides in vitro 
and this function is carried out by the substrate binding domain (30). The specific interaction was 
localized to the SBD β by deletion mutagenesis (60, 106, 107, 109). Prior to this study a mutant of any 
Hsp110 protein that inhibited substrate interactions while retaining the NEF function had not been 
identified therefore the substrate binding function was never characterized in vivo. C-terminal 
truncations produce unstable proteins that cannot interact with Hsp70 to induce nucleotide exchange 
because this interaction is partially mediated by the SBD α of Hsp110 (45, 60). Separating these two 
Hsp110 roles was integral to understanding the role each function was playing. Furthermore, by 
separating the NEF and SBD activities it was possible to study how each contributes to chaperone 
complexes.  
Based on work published by other labs, I created a mutant that targeted the putative peptide 
binding site of Sse1 (60). The mutant contained four amino acid substitutions within the Sse1 SBD β. 
For the first time a stable and NEF functional protein was available to characterize Sse1 holdase 
function independent of its other roles. The SBD defective mutant, Sse1sbd, was tested for its ability to 
complement the established slow growth phenotype of sse1∆ cells. Sse1sbd was not able to rescue the 
growth sensitivity under specific proteomic stressors such as heat and formamide. Moreover, the 
Sse1sbd protein was able to rescue nonviable sse1∆sse2∆ cells but was insufficient to rescue those cells 
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at elevated temperatures likely due to the absence of Sse2, In cells that expressed SSE2, with an intact 
NEF and SBD, some Hsp110 activity was providing additional support to the chaperone network. This 
was striking evidence that substrate binding by Sse proteins is required under specific stresses.  
 
Hsp110 contribution to Hsp70 functions 
 
 This study assessed the contributions of NEF and SBD activity of Hsp110 in Hsp70-mediated 
chaperone functions. In the absence of Sse1 function the HSR is activated even if cells are grown 
under optimal conditions likely because of general protein misfolding that is occurring (131, 132). 
Interestingly, when cells where grown under optimal conditions, the NEF-defective Sse1 strain 
demonstrated high activation of the HSR indicating that those cells were under proteomic stress due 
to the non-functional SSE1 allele they were expressing. I tested the activation of the HSR in cells that 
carried an Sse1 with proper NEF activity but deficient in substrate interactions (chapter 4). Cells 
expressing the substrate binding deficient sse1sbd also demonstrated an activation of the HSR, but it 
was not as robust. These results are evidence that the Sse1 SBD partially contributes to proteome 
maintenance but not to the extent that NEF function contributes. Another recognized Sse1 role is its 
requirement in complex with Hsp70 and Hsp90 to promote maturation of protein clients. During cell 
wall stress, the cooperative Hsp110-Hsp70-Hsp90 complex is required for the maturation of the Slt2 
kinase which signals through the cell integrity pathway and activates the transcription factors SBF and 
Rlm1 (161). In the same way, maturation of the glucocorticoid receptor (GR) requires Hsp110-Hsp70-
Hsp90 complex (114). A mature GR can activate the transcription of genes with GR elements (GRE) in 
the promoter. I used the GR with GRE-lacZ system to assess the extent to which the Sse1 NEF or SBD 
activities supplemented this Hsp70-Hsp90 mediated role.  I hypothesized that Sse1, through its 
holdase function, along with Hsp70 would maintain substrate in a competent state for Hsp90 
activities, but the data indicate that the Sse1 NEF activity played the predominant role in GR 
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maturation. In conclusion, the Hsp70-mediated Sse1 roles we tested showed that the SBD functions 
contributes minimally to the tasks of the chaperone complex. Although I observed striking 
phenotypes in the growth of cells expressing the SBD defective mutant under proteomic stress, this 
could be due to a slight decrease in efficiency across multiple Sse1 or Hsp70 complex roles. It could be 
that the slight deficiency across multiple functions compounds to produce a prominent growth 
inhibition when the proteome is challenged.  
 In collaboration with Nadinath Nillegoda and the Bukau laboratory in Heidelberg, Germany, 
we tested how the Sse1 SBD might contribute to the disaggregating and refolding function of the 
Hsp70-Hsp40-Hsp110 machine. These in vitro experiments demonstrated that the Sse1 SBD is not 
required for this function. It seems that the nucleotide exchange capacity of Sse1 is sufficient to drive 
the protein folding machine. Previously published data are contradictory regarding whether or not the 
Hsp110 can dissaggregate proteins in vitro collaboratively with Hsp40 and in the absence of Hsp70. 
Matoo et. al. have published reports that human Hsp110 (HSP105 and Apg2) can act with Hsp40 in 
the absence of Hsp70 to effectively refold denatured proteins and solubilize aggregates (111). This 
activity would surely require substrate binding by the Hsp110 chaperone. Contradicting this model, 
other published studies indicate that Hsp110 cannot function to dissaggregate or refold proteins in 
the absence of Hsp70 (110, 155). They propose that it is through the Hsp110 NEF function that the 
Hsp70-Hsp40-Hsp110 complex tackles protein aggregates. If Hsp110 can function as a dissaggregase 
independent of Hsp70, it is reasonable to predict that the SBD function would be required to interact 
with aggregated substrates. Along these lines, I did not explore the role that Sse1 might be playing in 
repairing damaged proteins that are unfolded or worse, have segregated into aggregates. Analysis of 
dissaggregation and refolding conducted in vivo would address this question. There is still much to 
learn about the function of Hsp110 dissaggregase activity and if the SBD function plays any role. 
The extent to which the substrate binding function of Sse1 is contributing to de novo protein 
folding remains unexplored in other Hsp70 roles. Yeast possesses two distinct cytosolic yeast Hsp70 
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systems. Whereas the SSA proteins are primarily involved in the rescue of stress denatured proteins 
and helping cells tolerate stress, Ssb1/Ssb2 (SSB) play a major role in folding nascent polypeptides and 
are dedicated to assisting protein biogenesis due to their localization to the ribosome (176). Once SSB 
has released the ribosomal complex and is still substrate-bound, it interacts with Sse1 to induce 
nucleotide cycling and peptide folding (83, 84). sse1∆ cells demonstrate growth sensitivity in the 
presence of translation inhibitors hygromycin and cycloheximide (176).  Additionally, sse1∆ cells 
display high degree of overall protein aggregation which is increased further upon the deletion of the 
nascent-polypeptide associated complex (NAC) which is functionally connected to SSB-mediated 
protein folding (177). The NEF Snl1, a Bag-1 protein that is tethered to the endoplasmic reticulum (ER) 
membrane, interacts with SSB in complex with the ribosome potentially to promote the nucleotide 
exchange in SSB (82). Fes1, another abundant cytosolic NEF does not interact with SSB and only forms 
a complex with Ssa proteins, (82, 132).  The distinct post-ribosomal interactions of Sse1 suggest a role 
in which this NEF contributes to folding or delivery of SSB substrates. It remains to be explored 
whether Sse1 binds unfolded nascent chains while also interacting with SSB to induce nucleotide 
cycling during de novo folding. The study discussed in this thesis tested the role of Sse1, focusing on 
the substrate interaction function, in assisting the maturation of glucocorticoid receptor via Hsp90. 
Sse1 has been implicated in in the processing or maturation of other yeast clients. For example, Sse1 
can aid in the translocation of the yeast mating pheromone ppαF, in maintaining the v-Src tyrosine 
kinase properly folded, and maturation of the Slt2 kinase via an Hsp70-Hsp90 interaction (44, 142, 
161). While the experiments testing the ability of sse1sbd or SSE1-RFA strains to activate the 
glucocorticoid receptor did not demonstrate a striking defect, I cannot rule out that the SBD or C-
terminus of Sse1 plays a role in maturation of other protein clients.   
 Evidence suggests that Sse1 plays a major role in modulating the ubiquination of Hsp70 
substrates that are irreparable. Sse1 is required for proper ubiquitination of misfolded cytoplasmic 
substrates such as truncated Gnd1 (tGnd1), the mutant vacuolar protease CPY (CPYǂ), unstable DHFR 
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mutants, and the artificially ubiquitinated substrate UbV76-Ura3 (133, 153). Sse1 is known to associate 
with the von Hippel-Lindau (VHL) tumor-suppressor protein, when expressed in yeast, to promote its 
degradation in association with Hsp70 (178). Moreover, Sse1 modulates the activity of the E3 
ubiquitin ligases, Ubr1 and San1, in vivo (133,153) . I assessed the role that Sse1 plays in targeting 
misfolded proteins for proteolysis by testing the Sse1nbd, Sse1sbd, and the Sse1-RFA mutants in their 
ability to degrade CPYǂ-GFP. The Sse1sbd mutant displayed proper clearance of the misfolded 
substrate, whereas Sse1nbd and Sse1-RFA could not fulfill this Sse1 function. The results for the Sse1nbd 
strain are expected as this mutant has limited interaction with Hsp70 and therefore cannot 
participate in a chaperone complex. It was surprising that Sse1-RFA cells demonstrated a defect so 
distinct from the Sse1sbd strain. One explanation could be that the RFA moiety that is fused to Sse1 
might interfere with allowing a ubiquitin ligase to access the permanently damaged protein substrate. 
It is important to note that Fes1 has also been implicated in promoting the degradation of the 
unstable DHFR mutants, but it plays no role in targeting CPYǂ or UbV76-Ura3 for proteolysis (132, 153). 
This is evidence that there are functional and substrate distinctions between an Hsp70-Fes1 and an 
Hsp70-Sse1 complex although these remain undefined. As I have mentioned previously, the substrate 
binding and interactions have been characterized using model substrates, but it remains unknown 
which native proteins are Sse1/Hsp110 substrates in vivo. The studies cited here and those that will 
follow are important in defining the subset of proteins within the proteome of eukaryotes that are 
Hsp110 dependent. Understanding this will further our ability to comprehend the mechanisms by 
which chaperone networks prevent human disease.   
 
The metazoan dissagregase  
 
After stress, cells need to solubilize and reactivate aggregated proteins. Functional proteins 
need to be refolded into their native state while terminally damaged proteins need to be cleared from 
106 
 
the cell. Prokaryotes and non-metazoan eukaryotes have a well characterized dissaggregation system 
which involves a powerful Hsp100 AAA+ ATPase, represented by Hsp104 in yeast (1, 13, 179). Hsp104 
recovers proteins from aggregates as it threads polypeptides through the ring formed by the hexamer 
and delivers these to Hsp70 (26). In concert with Hsp70 and Hsp40, Hsp104 acts a machine that can 
break polypeptide loose from protein aggregates (1, 180). 
Metazoans lack an Hsp100 protein that functions as a dedicated dissaggregase which raised 
doubts about the ability of metazoan cells to clear aggregates. Recent work has established that a 
metazoan dissaggregase composed of Hsp70-Hsp40-Hsp110 can disassemble aggregates and refold 
proteins (54, 110, 111, 155). Hsp40 targets Hsp70 to damaged substrates and Hsp110 functions as the 
preferred NEF to trigger aggregate dissolution (53, 110). Hsp110 is represented in mammals as three 
homologs, Hsp105α, Apg-1, and Apg-2 and is one of three classes of cytosolic NEFs which include the 
HspBP1-type and the Bag-type. In parallel to the studies cited, which characterized the dissagregase 
machine in vitro, Hsp105α knockout mouse cells were impaired in reactivating aggregated heat-
denatured luciferase (181). Likewise, a study in C. elegans also showed defects in aggregate clearance 
when Hsp110 was depleted (110). These data indicate that Hsp110 proteins have a distinctive 
function that other NEFs in metazoans cannot accomplish.  
Taking into account that the Hsp100 proteins in bacteria and fungi act in concert with Hsp70 
and Hsp40 to create a machine which can “pull” aggregates apart to produce free polypeptides, it is 
possible that the substrate binding function of Hsp110 chaperones is required to propel this machine. 
The study presented in chapter 6 forms the basis for this next line of investigation. Using the D. 
melanogaster Hsp110 (Hsc70cb) chaperone mutant collection I proposed, a member of my 
laboratory, Unekwu Yakubu, is currently addressing this question. Finding mutants of Hsp110 that can 
isolate the NEF and the SBD functions is imperative to understand the molecular mechanism by which 
this chaperone modulates aggregates. These mutants can be tested in vitro using the aggregation 
assay described in chapter 3 with a polyglutamine protein substrate or by developing a 
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dissaggregation and refolding assay. Beyond the biochemical characterization, the Hsc70cb mutants 
can be used to investigate the role of Hsp110 substrate interactions in the previously characterized 
fruit fly model polyglutamine-based neurodegeneration (125). 
 
Implications of Hsp110 in molecular progression of neurodegeneration  
 
Cellular proteostasis collapses when cells experience chronic proteotoxic stress and can lead 
to an accumulation of misfolded proteins. With the progression of age, cells also accumulate 
mutations that can produce toxic protein species (21, 28). Protein misfolding and aggregation have 
serious consequences for human disease ranging from many neurodegenerative diseases to diabetes 
(182). Neurodegeneration in disorders like Alzheimer’s (AD), Parkinson’s (PD), Huntington’s (HD) 
disease, and Amyotrophic Lateral Sclerosis (ALS) are characterized by protein aggregates or plaques 
that form in and around neurons (120). In vitro and in vivo studies have demonstrated that molecular 
chaperones, particularly Hsp110, can modulate protein aggregation and can lessen the effect of the 
toxic protein species that cause cellular degeneration (28). Hsp110 proteins have been effective in 
preventing toxicity caused by hyperphosphorylated tau, polyglutamine proteins, and mutant SOD1 in 
mice, flies , and nematodes respectively (123-127). Hsp110 association with polyglutamine proteins 
and SOD1 mutants has been demonstrated in animal models (124) (127). The proteins that cause 
neurodegenerative disorders are not necessarily similar other than their common β-sheet rich regions 
that lead to aggregation and form stable amyloid fibrils (120). As mentioned in the previous section, 
humans do not possess the traditional Hsp100 dissaggregase, but there is evidence that the Hsp70-
Hsp40-Hsp110 complex can fulfill this role in metazoans.  
These discoveries are recent and much is still unknown about the molecular mechanism that 
Hsp110 alone or in concert with Hsp70 is playing to modulate the effects of these toxic proteins. For 
example, Hsp110 is able to delay the onset of neurodegeneration by preventing the formation of 
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plaques, but it remains unclear how this occurs. Does Hsp110 help to fold amyloid-prone proteins to 
prevent the formation of amyloid plaques? Does Hsp110 act to hold amyloidogenic proteins in a 
soluble state until other chaperones can perform protein triage? Does Hsp110 promote the 
degradation of the amyloidogenic proteins directly? If the molecular mechanisms by which this is 
achieve can be understood, that specific chaperoning activity can be targeted to slow disease 
progression. Currently no treatments exist which can cure or reverse the impacts of 
neurodegenerative diseases. An incomplete understanding of molecular chaperones and the 
mechanisms by which specific substrate damage can be cleared or prevented to reverse proteome 
damage has resulted in limited therapeutic options.   
 
Hsp110 holdase as a clinical tool 
 
Finally, HSPs are currently being investigated for their benefits as vaccine adjuvants and are 
used to deliver antibodies, peptides, and antigens (183). Recent reports have indicated that Hsp110 is 
an excellent candidate to use when trying to deliver vaccine immunogens. It is particularly the ability 
of Hsp110 to bind substrate tightly and to chaperone vulnerable proteins that made it useful.  Hsp110 
can form a chaperone complex with large protein substrates, so researches are exploiting this 
chaperone function to deliver highly immunogenic cancer vaccines which can suppress tumors (184). 
For example, the intracellular domain (ICD) of HER-2/neu, an antigen relevant to breast cancer, was 
used in a complex with Hsp110 to elicit a specific immune response to the ICD without having 
secondary effects due to the presence of chaperone (185). These therapeutic application of the 
HSp110 substrate binding capability have been successful and are currently being utilized in clinical 
trials (186). In conclusion, Sse1/Hsp110 are worthy candidates to explore eukaryotic proteome 
maintenance for their capacity of modulate disease as well as their potential use to chaperone 
substrates that need to be delivered as therapies.  
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